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I.  The role of the Id2 protein in cell cycle, cancer and 
neurobiology 
 
 
I.1  Introduction 
 
Transcription factors are proteins that bind directly to a specific DNA sequence or 
to other DNA-bound proteins, in order to promote or block the expression of a target 
gene. The most common DNA-binding motifs found in proteins are the helix-turn-helix 
(HTH), the zinc-fingers, the leucine-zipper (LZ) and the helix-loop-helix (HLH). The 
family of the HLH transcription factors includes more than two hundred members 
which have been identified in a variety of organisms from yeast to mammals and can 
be classified in four different groups, depending on the presence or absence of 
additional functional domains along with the HLH motif (Figure 1) [1].  
 
 
 
Figure 1: Classification of the HLH transcription factors based on the presence or absence of 
additional functional domains along with the HLH motif (b = basic region, DNA-binding site).  
 
Another type of classification of the HLH proteins (classes I-VII) is based on their 
tissue distribution, dimerization capabilities and DNA-binding specificities. For 
example, class I [2] includes bHLH proteins which are ubiquitously expressed, 
like the factors E12 and E47, whereas class II includes mostly tissue-specific 
bHLH proteins, like NeuroD [3] and the myogenin-regulating factors MyoD and 
Myf5/6 [4]. Classes III (e.g. TFE3) and IV (e.g. Mad) contain HLH factors with 
an additional leucine-zipper C-terminal to the HLH region. Class V (emc and Ids) 
consists of proteins lacking the basic region N-terminal to the HLH motif which is 
essential for DNA binding, whereas class VI (e.g. HES-1) includes bHLH factors 
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displaying a conserved proline residue within the basic region. Finally, class VII 
(e.g. AHR) contains bHLH proteins with a conserved PAS domain C-terminal to 
the HLH motif. 
The HLH proteins are highly conserved in the HLH region that consists of 
two amphipathic α-helices connected by a loop and is required for homo- and 
heterodimerization. Only after dimerization the bHLH proteins are able to 
recognize and bind a consensus DNA sequence, so called E-box (CANNTG), 
through the two correctly oriented basic regions (Figure 2). Therefore, protein 
dimerization by the formation of a parallel four-helix bundle is used to convert 
inactive monomeric molecules into transcriptionally active dimeric complexes at a 
specific time during cellular development [5]. Indeed, this mechanism underlies 
the bHLH-mediated regulation of the expression of tissue-specific- and cell-cycle-
related genes [6-8]. 
 
 
Figure 2: Crystal structure of the bHLH dimer of MyoD bound to DNA (PDB ID: 1MDY) [9]. 
 
 
I.2  The Id Proteins 
 
The Id proteins (Id1 to Id4) belong to class V of the HLH transcription 
factors and are characterized by the absence of the DNA-binding region. They are 
involved in the control of cell-cycle progression and cell differentiation during 
development of many different cell types including nerves, muscles, cartilage and 
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bones. The name Id is related to the most important role of these proteins, which 
is that of being inhibitors of DNA binding and cell differentiation.  
The four Id proteins are similar in size (13-20 kDa) and share a highly conserved 
HLH region, whereas the rest of the sequence is unique for each protein. The Id 
HLH motif allows for dimerization with the related bHLH proteins of classes I 
and II, supposedly by forming a four-α-helix bundle stabilized by a combination 
of hydrophobic and electrostatic interactions. Due to the lack of the DNA-binding 
site, the Id proteins act as dominant-negative regulators of DNA transcription by 
sequestering ubiquitous (e.g. E47) and cell-type-restricted (e.g. MyoD) bHLH 
transcription factors, thus preventing the formation of the corresponding active 
dimers (Figure 3). 
 
 
 
Figure 3: Mechanism of action of the Id proteins. The formation of Id-bHLH dimers prevents 
bHLH transcription factors from forming transcriptionally active DNA-binding complexes. 
 
Whereas the Id proteins are widely expressed during development, they are 
low-expressed or absent in healthy adult cells. However, they are found to be 
overexpressed in many cancer types (Table 1) [10, 11]. 
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Table 1: Examples of tumors in which the Id protein expression is dysregulated [11].  
 
Tumor type Dysregulated Id protein 
Squamous cell carcinoma Id1, Id2, Id3 
Melanoma Id1 
Hepatocellular carcinoma Id1 
Colorectal adenocarcinoma Id1, Id2, Id3 
Pancreatic cancer Id1, Id2 
Thyroid cancer Id1 
Astrocytic tumor Id1, Id2, Id3 
Neuroblastoma Id2 
Ewing’s sarcoma Id2 
Ovarian tumor Id1, Id3 
Cervical cancer Id1 
Endometrial carcinoma Id1 
Breast cancer Id1, Id2, Id3 
Prostate cancer Id1, Id2 
Malignant seminoma Id1, Id2, Id3, Id4 
 
The Id proteins can contribute to tumorigenesis by inhibiting cell differentiation, 
while stimulating proliferation and favoring tumor angiogenesis. Although there is 
thus far no evidence that the Id proteins act as oncogenes, however, their 
overexpression might mimic the activity of oncogenes or the loss of tumor 
suppressor mechanisms.  
The role of the Id proteins in tumorigenesis, together with their low postnatal 
expression, makes them an attractive target for anti-cancer therapy [12]. 
 
 
I.3  The Id2 protein 
 
Among the Id proteins, Id2 has attracted much interest because it is the only 
one to be expressed in the adult cerebellum upon physiological conditions. 
Besides heterodimerization with the parent HLH factors, Id2 can bind the 
retinoblastoma protein (pRb) [13] and the related pocket proteins p107 and p130. 
Moreover, Id2 is likely to be a target of the proto-oncogene N-myc, whose 
amplification and overexpression are hallmark of neuroblastoma [14]. 
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Figure 4: Amino acid sequence (top) and representation (bottom) of the Id2 domains and of their 
interaction partners (see text for details).  
 
Id2 is a small protein consisting of 134 residues (Figure 4). The 41-residue long 
HLH motif is responsible of the interaction with the bHLH proteins and, probably, 
with pRb. The N-terminus contains a phosphorylation site at Ser-5 that negatively 
affects the inhibitory activity of Id2 [15]. Moreover, the N-end seems to be 
important for ubiquitination (UPS: ubiquitin-proteasome system) and consequent 
protein degradation [16]. The N-terminus has been also found to induce apoptosis 
by increasing the expression of the proapoptotic Bax gene [17]. Kurooka and 
Yokota have shown that the HLH region of Id2 is necessary for nuclear 
localization, whereas residues 106-115 in the C-terminus (NES: nuclear export 
signal) are required for the export of the protein from the nucleus into the 
cytoplasm [18]. The C-terminus contains also a destruction box (D-box) that is 
responsible of the interaction with the anaphase promoting complex/cyclosome 
(APC/C) and triggers the Id2 degradation [19]. 
 
 
 
 Introduction 6
I.3.1  The Id2 protein and cancer 
 
The Id protein research is mainly focused on the role of these proteins in 
cancer. Id2 is a potent effector in tumorigenesis. Aberrant overexpression of Id2 
has been associated, for example, with squamous cell carcinoma, colorectal 
adenocarcinoma, pancreatic cancer, astrocytic tumor, neuroblastoma, Ewing’s 
sarcoma, breast cancer, prostate cancer and malignant seminoma (Table 1). 
However, it has been also reported that mice lacking Id2 develop intestinal 
tumors, indicating a tumor-inhibitory function of Id2 in the intestinal epithelium 
[12, 20-23].  
 
 
I.3.2  The Id2 protein in the nervous system  
 
In the peripheral nervous system Id2 has a pivotal role in cell-fate 
determination and oncogenesis. Recent data show that Id2 is highly expressed in 
two pediatric neuroectodermal tumors, neuroblastoma and Ewing’s sarcoma 
(EWS). In these tumors, Id2 is constitutively activated by overexpression of N-
Myc and EWS-Ets chimera proteins, respectively [24-26]. 
There is clear evidence that the Id proteins are essential proliferative factors for a 
variety of cell types. Several studies suggest that the progression in the G1 cell-
cycle phase requires the cooperative action of Ids on their natural targets, like 
bHLH, Ets and Pax. In mammalian cells, a crucial checkpoint control for 
proliferation is provided by the pocket proteins of the Rb family (pRb, p107, 
p130). Id2 is the only member of the Id family that is able to bind to each of the 
three pocket proteins in a cell-cycle regulated fashion [27]. Apparently, the very 
few non-conserved amino acid residues in the HLH region of Id2 compared with 
the corresponding domains of Id1, Id3 and Id4 are likely to confer the binding 
specificity of Id2 to the Rb family members. 
Undifferentiated cells must overcome growth-inhibitory signals to maintain 
their proliferative potential, which requires the inactivation of negative regulators 
of cell-cycle progression, such as the pRb and the related pocket proteins. These 
share a stretch homologous sequence, so called pocket, which is necessary to bind 
other cellular proteins, including E2F, cyclins and MyoD. The interaction between 
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the Rb family members and these proteins results in the timely transcription of 
genes encoding factors essential for cell-cycle progression (E2F), or induction of 
the differentiated state (MyoD). Several studies indicate that pRb (or a related 
pocket protein) is required for differentiation of a variety of cell types. In normal 
cells, pRb activity is regulated by alternating changes in pRb phosphorylation. G1 
cyclins functioning as regulatory subunits of their partners cyclin-dependent 
kinases (Cdks) phosphorylate pRb, thus switching off its growth-inhibitory 
function. 
Id2 physically associates with the hypophosphorylated active form of pRb, and 
this interaction negatively regulates Id2. Conversely, high levels of Id2 negatively 
regulate pRb-mediated growth suppression, probably in a direct manner by Id2-
pRb association and, also, in an indirect manner by reducing the activity of the 
cyclin kinase inhibitors (CKIs) and altering the G1 cyclin-Cdk complexes [28].  
Disruption of the pRb pathway is a hallmark of cancer and it is widely 
accepted that normal pRb function must be removed in most of the human tumors. 
Extensive in vivo studies have been done to analyze the specific role of Id2 in 
driving the cell cycle. Comparison of genetic data from pRb-null and Id2-pRb-
double-null embryos indicates that the ectopic proliferation and differentiation 
both in the nervous system and in the haematopoietic compartment of the pRb-
null embryos are efficiently rescued by loss of Id2 [26]. Completion of normal 
development requires the inhibition of Id2 by pRb, which is essential for 
activation of the natural targets repressed by Id2 (bHLH and Ets-family members) 
[12]. 
Neuroblastoma, a tumor of the sympathetic nervous system, is the most 
common extracranial solid cancer in infants and children. Genomic amplification 
of the gene N-Myc is found in about 25% of primary neuroblastomas, which is 
one of the most reliable independent prognostic factors for this disease. N-Myc 
amplification clearly correlates with advanced stages of illness and is associated 
with poor outcome regardless of stage or age. Tumors holding this amplification 
are often refractory to treatment [29, 30]. Myc proto-oncogenes directly bind to 
the Id2 promoter activating it (Figure 5). By rising Id2 levels, Myc proteins avoid 
the blockage of cell-cycle progression imposed by the pRb pathway.  
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Figure 5: Role of pRb and Id2 in neuroblastoma. 
 
This holds also for neuroblastoma cell lines carrying N-Myc gene amplification. 
Id2 expression determines the rate of proliferation of primary, immortalized and 
tumor cell lines. An immunohistochemical analysis of primary neuroblastoma 
shows that the expression of Id2 is strongly predictive of poor outcome. 
Overexpression of Id2 mediates cellular transformation and is required to 
maintain the malignant behavior of neuroblastoma cells [14]. Id2 is also a target 
for c-Myc and there are studies suggesting a direct correlation between c-Myc and 
Id2-mRNA in primary neuroblastomas [31]. 
Ewing’s sarcomas (EWS) are highly malignant tumors arising in adolescents 
and young adults. They are characterized by a chromosomal translocation that 
results in the fusion of the 5' sequence of EWS with the 3' portion of various 
genes of the Ets oncoprotein family. The EWS-Ets chimera proteins act as 
aberrant transcription factors that can lead to oncogenic transformation. Id2 is a 
direct downstream target and potential mediator of the oncogenic EWS-Ets 
proteins. In addition, Id2 is highly expressed in EWS primary tumors, which may 
explain the high malignancy and poor prognosis of this disease. Thus, the 
oncogenic process of EWS may be attributed to the Id2-mediated inhibition of 
pRb that has a tumor suppressive activity in a series of cancers. Again, the 
Myc/Id2 pathway plays a crucial role in the tumorigenic process, as the induction 
of the Id2 gene is increased by Myc oncoproteins that are up-regulated by the 
EWS-Ets chimera proteins [24, 28, 32]. 
The cellular localization of Id2 has been recently proposed to be critical for 
the regulation of its function. In spite of the fact that other biological conditions 
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may regulate subcellular compartmentalization of Id2, the process of 
differentiation requires nuclear exclusion of the small protein. Cytoplasmic 
sequestration of Id2 has been described in two models of neuroectodermal and 
haematopoietic differentiation [18, 33]. Recently, the actin-associated protein 
enigma homolog (ENH) has been reported to act as a cytoplasm retention factor 
for Id2 [34]. ENH, whose expression increases during neuronal differentiation, 
sequesters Id2 in the cytoplasm and prevents cell-cycle progression and inhibition 
of bHLH driven by Id2. ENH belongs to a family of adaptor proteins that are 
anchored to the actin cytoskeleton. It possesses LIM domains, cysteine-rich 
double zinc fingers motifs known to mediate protein-protein interactions. Id2 
nuclear shuttling is inhibited by the formation of a complex between the LIM 
region and the HLH motif. Therefore, ENH contributes to the differentiation of 
the nervous system and is a restraining factor of the oncogenic activity of Id2 in 
neuronal tumors [34] 
 
 
I.3.3  The Id2 protein and the lymphatic system  
 
Recent studies have established a role of Id2 in lymphopoiesis. Surviving 
Id2-/- mice display a cell intrinsic defect in production of natural killer cells 
involved in immune function and also lack secondary lymphoid follicles of 
Peyer’s patches in the intestine [35].   
Hodgkin’s lymphoma is one of the most common cancer forms in the lymphatic 
system. Pathologically, it is characterized by the presence of Reed-Sternberg cells 
deriving from a B lymphocyte (white blood cell) that has become cancerous. The 
Id proteins block B lymphocytes maturation at an early differentiation step, as 
demonstrated by gain-of-function studies [36]. Upon B cell activation, Id2 acts as 
a negative regulator to prevent potentially harmful effects caused by excessive 
immunological reactions. One of its special roles is to maintain low serum 
concentrations of immunoglobulin E by antagonizing E2A and Pax5 activities, 
which are both required for proper B cell activation. Primary Hodgkin-
Reed/Sternberg (HRS) cells are characterized by the loss of B cell specific gene 
expression. Id2 is not detectable in normal B cells, whereas it is strongly and 
uniformly expressed in HRS cells in all cases of classical Hodgkin’s lymphomas. 
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Thus, aberrant Id2 expression contributes significantly to the loss of B cell 
specific gene expression in HRS cells by inhibiting E2A and, probably, Pax5 [36-
38]. 
 
 
I.3.4  The Id2 protein can drive to apoptosis 
 
Apoptosis is one of the main mechanisms of programmed cell death (PCD), 
a process of deliberate life abandon by a cell in a multicellular organism. In 
contrast to necrosis, a form of cell death that results from acute cellular injury, 
apoptosis is carried out in an ordered process that generally confers advantages 
during an organism’s life cycle. Defective apoptotic processes have been 
implicated in an extensive variety of diseases. Too much apoptosis causes cell-
loss disorders, whereas too little results in uncontrolled cell proliferation, namely 
cancerous tumors. 
The tendency of cells to undergo apoptosis when receiving divergent growth 
signals may result from a deregulated expression of cell-cycle modulators and the 
activation of their target genes at the wrong time. Apoptosis as well as all PCD 
processes are highly-controlled events. A feature shared by some positive 
regulators of mammalian cell-cycle progression is their ability to drive apoptosis 
when ectopically overexpressed [39, 40]. Several groups have reported on the pro-
apoptotic properties of Ids in cell lines and in primary cell models. PCD induced 
by Id2 is recognizable as apoptosis by several criteria, including morphology, 
analysis of DNA fragmentation and of sub-diploid DNA content. Overexpression 
of Id2 increases apoptosis of 32D.3 cells, an interleukin-3 (IL-3)-dependent 
myeloid progenitor cell line, and of U2OS cells, an osteogenic sarcoma-derived 
cell line [17]. Id2 might drive apoptosis through a pathway that is different from 
the one utilized by the other Ids: in fact, Id2-induced apoptosis is independent of 
HLH-mediated dimerization and is not based on the interaction with the bHLH 
proteins [39, 40]. Florio et al. [17] have shown that the N-terminal region of Id2 
and not the HLH motif is necessary for the enhancement of apoptosis: indeed, Id2 
expression led to high mRNA levels of the pro-apoptotic molecule Bax in 32D.3 
cells, and deletion of the Id2 HLH domain even incremented the PCD rate. Two 
models are suggested to explain such Id2 action. In the first model, the Id2 N-
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terminal region is proposed to directly interact with the transcription factor 
complex mediating the expression of cell death genes within the nucleus. In the 
second model, the cytoplasmic Id2 pool might regulate cell death by binding 
molecules mediating or regulating apoptosis. In both models, these interactions 
would occur independently of dimerization via the HLH domain. However, Id2 
enhancement of PCD may still be antagonized by proteins that normally bind to 
the Id2 HLH domain and may be physiologically regulated by the availability of 
HLH binding partners. 
In a recent study the molecular regulation of apoptosis in fast plantaris 
muscles has been investigated [41]. Plantaris muscle mass has been found to be 
22% lower in aged rather than in young adult animals, with the apoptotic index 
being 600% higher in the aged animals. This study also showed that changes in 
pro-apoptotic mRNA for apoptotic protease activating factor-1 (Apaf-1), Bax and 
Id2 are increased with aging. Bax and Bcl-2 protein levels were also altered 
differently in aged muscles when compared to young muscles. Significant positive 
correlations were observed between the changes in Id2 and Bax mRNAs, and Id2 
and caspase-9 mRNAs. These data suggest that a pro-apoptotic environment may 
contribute to aging-associated atrophy in fast skeletal muscles, but apoptotic 
signaling differs by age [41]. Therefore, Id2 is a multifunctional protein that 
works as a gatekeeper of the G1/S transition of the cell cycle [17]. 
 
 
I.3.5  Id2 protein activity regulation 
 
Regulation of the level and of the activity of the Id proteins provides the cell 
with an important mechanism to control the balance between the active and 
inactive form of many bHLH transcription factors. Id proteins can be regulated at 
different levels, for example by transcriptional regulation, post-translational 
modifications and protein stability. Hara et al. [15] have reported that Id2 can 
undergo cyclin A(E)-Cdk2 mediated phosphorylation of a specific serine residue 
(Ser-5) in the N-terminus, where there is a consensus sequence for Cdks (Ser-Pro-
Val-Arg), which is also present in Id2, Id3 and Id4. Phosphorylation prevents Id2 
from interfering with the formation of DNA-binding complexes in vitro. 
Moreover, in serum-stimulated human diploid fibroblasts, phosphorylation occurs 
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in the late G1, which correlates with the activation of cyclin E-Cdk2 and with the 
formation of a specific DNA-binding complex that would otherwise be prevented 
by excess of Id2. Therefore, Id2 must be phosphorylated to allow cell-cycle 
progression, and this event provides a link between the Cdk and bHLH activities, 
which may be crucial for the regulation of cell proliferation and differentiation. 
Besides phosphorylation, Id2 activity in the cell is regulated also via the 
ubiquitin-proteasome system (UPS) that is responsible for specific degradation of 
numerous cellular regulatory proteins. The UPS activity involves the generation 
of a substrate-anchored polyubiquitin degradation signal and the destruction of the 
tagged protein by the 26S proteasome, followed by the release of free and 
reusable ubiquitin. The formation of ubiquitin conjugates requires the sequential 
action of three enzymes: E1, an ubiquitin-activating enzyme, E2, an ubiquitin 
carrier protein, and E3, a member of the ubiquitin-protein ligase family. In most 
cases, the first ubiquitin molecule is transferred to an ε-NH2 group of an internal 
Lys residue. However, Id2 follows an N-terminal ubiquitination pathway, in 
which modification occurs at the N-terminal residue, whereas recognition of E3 
probably involves a downstream motif. 
Fajerman et al. [16] have reported that Id2 is ubiquitinated in an ATP-dependent 
manner in a cell-free reconstituted system. In addition, in this in vitro system the 
Ser-5/Ala Id2 mutant is equally sensitive to the UPS activity, thus excluding that 
phosphorylation of Id2 is a necessary signal for its ubiquitination and degradation. 
Lys-less (LL) Id2 analogue is degraded efficiently by the proteasome following 
ubiquitination, demonstrating that the first ubiquitin moiety is fused to the free α-
NH2 group of the protein. Fusion of a Myc tag to the N-terminal, but not to the C-
terminal residue of Id2 stabilizes the protein, an effect reached also by deletion of 
the first 15 N-terminal amino acids, which proves that this domain serves as a 
recognition element for the ubiquitin ligase E3. The mechanisms and structural 
motifs that govern Id2 stability may have important implications in the regulation 
of the protein during normal differentiation and malignant transformation. 
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I.3.6  Nucleo-cytoplasmic shuttling of the Id2 protein 
 
Appropriate subcellular localization is crucial for the proper function of 
numerous proteins. Some are constitutively nuclear, while others are actively 
transported into or out of the nucleus in a signal-dependent or -independent 
manner. Large proteins can shuttle between the nucleus and the cytoplasm 
through pore complexes due to their intrinsic nuclear localization signals (NLSs) 
and nuclear export signals (NESs). These domains are recognized by nuclear 
import and export receptors, respectively.  
Due to their small size (13-20 kDa), passive diffusion is the main mechanism 
dictating the subcellular localization of the Id proteins, but it is likely that other 
regulatory pathways also exist [42, 43]. Id2 can move from the nucleus to the 
cytoplasm during neuronal differentiation into oligodendrocytes [44], and it is in 
the cytoplasm also during myeloid precursors differentiation [33].  
Kurooka and Yokota [18] have shown that Id2 has the ability to shuttle between 
the nucleus and the cytoplasm. However, when passive diffusion is prevented by 
fusion with green fluorescent protein (GFP), Id2 is predominantly localized in the 
cytoplasm, and the C-terminus seems to be responsible for that. Id2 can be 
actively exported from the nucleus to the cytoplasm by a mechanism related to the 
chromosome region maintenance protein 1. In fact, Id2 contains two putative 
leucine-rich NESs, NES1 in the helix-2, and NES2 in the C-terminal region. 
Whereas the former is conserved among the Id members, the latter is 
characteristic only of Id2 and drives the nuclear export of the protein. This has an 
inhibitory effect on the Id2-mediated transcriptional repression, suggesting that 
the nuclear-cytoplasmic shuttling might be another type of post-translational 
regulation of the Id2 function [18].  
 
 
I.3.7  The Id2 protein promotes axonal growth 
 
The anaphase promoting complex/cyclosome and its activator Cdh1 
(APC/CCdh1) restrain axonal growth, but their targets in neurons are unknown. In a 
recent work, Iavarone and co-workers [19] have reported that Id2 interacts with 
subunits of the APC/C complex in primary neurons. Expression of Cdh1 causes a 
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marked decrease in Id2 levels, an effect that can be prevented by proteasomal 
inhibition. Interestingly, activation of APC/CCdh1 can prevent the sequestering of 
E47 by Id2 as well as by an Id2 mutant lacking the 15 N-terminal residues 
necessary for Id2 degradation via ubiquitination. APC/CCdh1 triggers Id2 
degradation through a destruction motif (D-box, residues 100-107) that is located 
at the C-terminal domain and is also present in Id1 and Id4. APC/CCdh1 directs cell 
cycle-independent functions in postmitotic neurons, including the negative control 
of axonal growth. Activity of the Id proteins, which are depleted in quiescent 
cells, corresponds to the effect of inactivation of APC/CCdh1 in postmitotic cells. 
As a matter of fact, overexpression of Id2 prevents cell-cycle arrest by a wide 
range of antiproliferative signals. Upon certain experimental conditions, ectopic 
Id2 is able to override the quiescent state and drive terminally differentiated cells 
back into the cell cycle. Id2 analogues containing mutations in the D-box enhance 
axonal growth in cerebellar granule neurons in vitro and overcome the myelin 
inhibitory signals for growth. In contrast, activation of bHLH transcription factors 
induces a cluster of genes with potent axonal inhibitory functions, including the 
gene coding for the Nogo receptor, a key transducer of myelin inhibition. 
Degradation of Id2 in neurons leads to accumulation of Nogo, linking the 
APC/CCdh1 activity with bHLH target genes for the inhibition of axonal growth 
(Figure 6). Therefore, up-regulation of Id2 activity might be useful to reprogram 
quiescent neurons into the axonal growth mode [25]. 
 
 
 
Figure 6: The role of Id2 during neuronal maturation. 
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I.4  Conclusions and perspectives 
 
Therapeutic strategies based on Id protein targeting, in particular Id2, might 
be important for cancer patients, given the clear relationship of Id protein 
expression with aggressive cancer cell behavior. Drugs neutralizing the action of 
Id2 in tumors like neuroblastoma might reconstitute the integrity of the pRb 
pathway, the most critical antiproliferative defense available in mammalian cells. 
On the other hand, thinking of the ability of Id2 to promote axonal growth, 
specific molecules preventing Id2 degradation, thus allowing immature neurons to 
grow, would represent a hope for patients with spinal cord injuries. 
 
While a lot of efforts have been made to study the biological and 
pathological aspects of the Id proteins, not much is known on their biophysical 
and structural features, although their mode of action is strongly dependent on the 
ability to fold into stable HLH domains which allow for homo- and 
heterodimerization with related bHLH proteins. Moreover, the N- and C-termini 
of the Id proteins have been shown to contain key motifs that exert important 
regulatory functions. The presented Ph. D. thesis has focused on a chemical 
approach to prepare large polypeptides based on Id2 and related analogues as 
tools for conformational investigations. Such synthetic and spectroscopic studies 
should be complementary to the biochemical ones and contribute to the further 
understanding of the complex behavior of the Id2 protein as well as to the future 
development of artificial Id2 protein modulators. 
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II.  A chemical approach to the synthesis of large Id2 protein                    
fragments [1] 
 
 
II.1  Introduction 
 
Due to its implication in tumorigenesis and tumor growth, the Id family is a potential 
target for the diagnostics and therapy of tumor diseases, in which an increased Id protein 
activity has been detected [2]. Therefore, it is important to characterize these proteins from a 
biochemical and structural point of view, with the long-term aim of developing artificial 
molecules capable of modulating the Id function in pathological sceneries in a specific and 
efficient manner.  
As described previously in chapter I, among the Id proteins, Id2 has attracted much interest 
because of its ability to bind pRb and the related pocket proteins, and because of the fact 
that it might be a target of the proto-oncogene N-Myc, whose amplification and 
overexpression are hallmark of neuroblastoma [3]. Our interest for this protein is related to 
its conformational properties and to the structural prerequisites dictating its unique protein–
protein interaction profile. For this purpose, we decided to use a synthetic approach that 
would allow the preparation of a variety of polypeptides related to the native as well as 
chemically modified Id2 protein for structural studies. Therefore, we investigated the 
accessibility of large Id2 fragments by standard solid-phase peptide synthesis (SPPS). The 
sequence 36-110 was the largest one that could be assembled by stepwise SPPS in 
combination with the 9-fluorenylmethoxycarbonyl (Fmoc) strategy. Unfortunately, 
fragments containing the complete C-terminal region (residues 77-134) turned out to be 
poorly accessible with this chemical approach, which should be attributable to strong 
peptide chain aggregation during elongation. Peptide aggregation also prevented the 
possibility to obtain the full length C-terminal domain by native chemical ligation [4]. 
The secondary structure of the synthetic Id2 analogues was analyzed by circular dichroism 
(CD) spectroscopy. Noteworthy, all fragments containing the C-terminal sequence 77-110 
showed low solubility and/or high tendency to aggregate. Even the usually highly stable Id2 
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HLH motif was negatively affected by the C-terminal elongation of helix-2, suggesting that 
this flanking region could modulate the folding and stability of the adjacent domain [1]. 
 
 
II.2  Chemical synthesis of Id2 protein fragments 
 
 
II.2.1  The C-terminal fragments 
 
The C-terminal domain of Id2 (product II.1, Table 1) consists of 58 residues, 
including a considerable number of the β-branched Leu (8) and Ile (4), as well as of Ser (9), 
Thr (5), Asx (6) and Glx (6). Peptide chain assembly starting from the C-end, Gly-134, 
using Fmoc chemistry and standard solid-phase procedures led to a crude peptide with very 
low homogeneity (Figure 1A), which prevented any attempt of purification. Instead, the 
shorter fragment 99-134 (II.2) was obtained as the major product (Figure 1B) and was then 
efficiently purified by preparative RP-HPLC. This suggests that the synthetic problems 
encountered in the preparation of the fragment 77-134 occurred during elongation from 
residue 98 to residue 77. However, the fact that the sequence 77-124 (II.3) was obtained 
with good homogeneity (Figure 1C) indicated that the difficulty of peptide chain assembly 
was dependent on the starting position. Indeed, when Glu-119 was chosen as the C-terminal 
residue, even after only 16 couplings a complex mixture of products was cleaved from the 
resin (product II.4, Table 1 and Figure 1D), which could not be further identified by mass 
spectrometry. The different accessibility of the last two Id2 fragments presumably reflected 
different aggregation propensity of the peptide chains; in fact, starting from Leu-124 rather 
than from Glu-119 was probably advantageous because the proline residue located four 
positions apart from the C-end, Pro-121, might have induced a backbone bending, thus 
reducing the aggregation of the growing sequence that was predicted to form preferentially 
β-sheets in the region 103-115 on the base of the Chou and Fasman analysis [5]. 
 
 
 
 Synthesis of large Id2 protein fragments 
 
22
Table 1: Amino acid sequence of the human Id2 protein and analytical data of the synthetic Id2 
fragments. 
Human Id2 a 
M1KAFSPVRSVRKNSLSDHSLGISRSKTPVDDPMSL35LYNMNDCYSKLKELVP51SIPQNK
KVS60KMEILQHVIDYILDLQ76IALDSHPTIVSLHHQRPGQNQASRTPLTTLNTDISILSLQA
SEFPSELMSNDSKALCG134 
Synthetic Id2 polypeptides 
No Chain 
length 
MWcalc.  
(Da) 
MWfound 
(Da) 
tR 
(min) 
II.1 77-134 b 6285.09 n. d. n. d. 
II.2 99-134 3912.44 3915 29.0 
II.3 77-124 b, c 5276.94 5278 28.0 
II.4 103-119 b, c 1860.11 n. d. n. d. 
II.5 61-110 b, c 5727.59 5729 21.5 
II.6 51-110 b, c 6806.87 6807.8 d 19.0 
II.7 [S-42]-(36-110) b, c 8605.96 8605.5 d 19.5 
II.8 60-76 b, c 2099.50 2100 21.5 
II.9 36-52 b, c 2058.42 2060 18.7 
II.10 36-76 b, c 4906.85 4907.7 d 20.5 
II.11 [Q-38, -40, E-41]-(36-76) b, c 4948.93 4949.7 d 21.5 
II.12 [Nle-39, -62, S-42]-(36-76) b,c 4854.71 4857 19.0 
II.13 [F-37, -43]-(36-76) b, c 4874,85 4877 20.99 
II.14 [F-37, -71]-(36-76) b, c 4874,85 4876 21.1 
II.15 [F-43, -71]-(36-76) b, c 4874,85 4875 21.4 
II.16 1-35 c 3843.48 3845 10.8 
a Underlined sequences: helix-1 (36-51) and helix-2 (61-76); double underlined sequence: loop 
(52-60). b The fragment is N-terminally acetylated. c The fragment is C-terminally amidated. d 
Determined by LC-ESI-MS (all others were determined by MALDI-ToF-MS). 
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Figure 1: HPLC profiles of crude peptides II.1 (A), II.2 (B), II.3 (C), and II.4 (D). 
 
 
It has been reported that solid-phase synthesis of peptides forming aggregates [6] 
could be improved by using the pseudoproline dipeptides developed by Mutter and co-
workers (Figure 2) [7]. 
 
 
 
Figure 2: The pseudoproline dipeptide developed by Mutter and co-workers [7]. 
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Pseudoproline dipeptides are masked serine or threonine residues that present some 
interesting features. First of all they allow the introduction of two residues in one step, and 
the side chain of serine or threonine can be regenerated by general cleavage conditions with 
TFA. Moreover, the introduction of a moiety that has a similar structure to proline helps 
disrupting secondary structure formation as well as aggregation. Additionally, peptides 
containing C-terminal pseudoproline dipeptide residues can be coupled without any risk of 
stereomutation. To obtain more effective results by using pseudoproline dipeptides, they 
must be introduced every four-six residues in the sequence, as it has been successfully done 
in the case of the human islet amyloid peptide (IAPP) [6]. 
As segment II.4 was a suitable candidate for the pseudoproline chemistry due to the 
presence of several Thr and Ser residues, the synthesis was repeated by introducing the 
pseudoproline at positions 111 and 114. However, also this approach led to a poorly 
homogeneous product. 
Another strategy that can be applied in the case of difficult sequences containing native 
serine residues is the depsipeptide strategy (Figure 3) [8, 9]. Insertion of a depsipeptide unit 
in a sequence interrupts the regular pattern of amide bonds at the site of a Ser/Thr unit, as 
from that point the peptide chain is extended via the β-hydroxyl function and not via the α-
amino function. Each depsipeptide unit provides an additional ionizable moiety, thereby 
increasing solubility and facilitating purification, as reported for the case of the amyloid 
peptide Aβ-(1-42) [10]. Conversion of the ester bonds to the target amide bonds is smoothly 
achieved through an O,N-acyl shift, which occurs quantitatively under mildly basic 
conditions over a short period of time. 
 
 
 
Figure 3: Conversion of a depsipeptide to the amide form through a base-promoted O,N-acyl shift. 
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This strategy was applied to assemble the Id2 peptide chain starting from residue 134, with 
the purpose of forming an ester bond between Ser-118 and Ala-117 or between Ser-114 and 
Leu-113 (Scheme 1). Unfortunately, in both cases the esterification reaction did not run to 
completion by using the conditions reported in the literature [8]. Therefore, further 
optimization of the reaction procedure is necessary to reach satisfactory results. 
 
 
Scheme 1: Synthesis of Id2 C-terminal peptides by the depsipeptide strategy (the yellow sphere represents the 
Wang resin; the blue rectangles are the growing peptide chains; the dotted arrows represent the reactions that 
would have brought to the desired product after a successful esterification step). 
 
 
 
 
In contrast to the synthetic difficulty of the Id2 sequence starting from Gly-134 (II.1), 
the Id2 sequence starting from Leu-124 (II.3) was chemically accessible by standard solid- 
phase methodology. However, this peptide was found to be only moderately soluble both in 
water and phosphate buffer, whereas it could be dissolved in methanol and in mixtures of 
methanol/water. 
Another good starting point for the synthesis of C-terminally truncated Id2 analogs was Ile-
110, as shown by the HPLC profiles of the crude products of peptides II.5-7 (Figure 4). For 
the synthesis of II.7 that contained the complete HLH motif with one mutation at position 
42 (Cys was replaced with Ser), the pseudoproline dipeptide Asp(OtBu)-Ser(ΨMe,Mepro) was 
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coupled instead of the single amino acids Asp-41 and Ser-42, to reduce the risk of chain 
aggregation during elongation [7]. 
 
 
 
Figure 4: HPLC profiles of crude peptides II.5 (A), II.6 (B), and II.7 (C).   
 
 
II.2.2  The HLH motif 
 
To investigate the intrinsic conformation of the two helices forming the HLH 
structural motif of Id2, the sequences 36-52 and 60-76 reproducing helix-1 and helix-2, 
respectively, were synthesized. Helix-1 (II.9) showed a major degree of difficulty in the 
chain assembly relative to helix-2 (II.8), as deduced by the different homogeneity of the 
corresponding crude products (Figure 5A-B). Also during the synthesis of the entire HLH 
motif (II.10) a consistent amount of byproducts was produced, which accumulated mostly 
in the region of helix-1 (Figure 5C). LC-ESI-MS analysis indicated the presence of the 
truncated sequences 43-76 and 42-76, and of the sequence lacking Cys-42. When the last 
couplings were carried out manually and monitored by the ninhydrin test [11], it was 
observed that especially Asp-41, Met-39 and Tyr-37 were difficult to be acylated. Longer 
coupling reactions and introduction of a capping step, however, did not lead to a significant 
improvement of the quality of the crude product. 
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Figure 5: HPLC profiles of peptides II.8 (A), II.9 (B), and II.10 (C) 
 
One side reaction that could have occurred during the synthesis of II.10 is the 
formation of aspartimide [12, 13]. In the Fmoc chemistry, this intramolecular cyclization 
can be catalyzed by the repetitive piperidine treatments needed for the Fmoc removal. 
Additional byproducts result from racemization of the imide moiety, ring opening by 
nucleophiles and even breakage of the backbone. Therefore, to exclude the formation of 
aspartimide, Asn-38, Asn-40 and Asp-41 were substituted by Gln and Glu (II.11). However, 
as the HPLC profiles of the crude peptides II.10 and II.11 were almost superimposable, it 
was concluded that the aspartimide formation, if ever occurred, was a minor event. 
A consistent byproduct of the synthesis of the HLH motif was its Met-oxidized species (+16 
Da), which resulted to be resistant against reduction with TMSBr/EDT/TFA. Peptide II.12 
containing the replacements Nle→Met-39/-62 and Ser→Cys-42 was prepared to have an 
HLH analog insensitive to oxidative processes and thus easier to handle, but it was 
obviously still contaminated by the same truncated and deleted sequences found for the 
native HLH peptide. 
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II.3  CD spectroscopy  
 
 
II.3.1  Peptides containing the Id2 C-terminal region 
 
The CD spectrum of the Id2 C-terminal segment 101-134 in phosphate buffer (100 
mM, pH 7.3) was reported [14] and resembled that of a random coil. Unfortunately, in the 
present work the synthesis of the full-length C-terminus 77-134 by stepwise solid-phase 
methodology and Fmoc chemistry was not successful, but it was possible to obtain the 
analogue spanning residues 77-124. Because of the very low solubility both in water and in 
phosphate buffer, the CD spectra of II.3 were recorded in methanol and methanol/water 
mixtures at a peptide concentration of 50 μM (Figure 6). A low-intensity, α-helix-like curve 
was recorded in methanol, which was characterized by two negative bands at 223 nm 
(amide n–π∗ transition) and 209 nm (amide π–π∗ transition), and by a positive band near 
190 nm with a crossover at 200 nm. The ratio R between the ellipticity values at 223 and 
209 nm was 0.75. Despite the helix-like shape, this spectrum is remarkably less intense than 
it is expected for an α-helix, which is probably due to peptide aggregation. Upon water 
addition, the CD intensity further decreased, and at water percentage ≥60% the shape 
changed from helix-like to random-like, showing a negative Cotton effect close to 200 nm. 
The absence of an isodichroic point suggests that it was not a two-state transition. 
 
 
 
Figure 6: CD spectra of peptide II.3 at the concentration of 50 μM in methanol and methanol/water mixtures. 
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Unlike peptide II.3, peptides II.5-7 were soluble in phosphate buffer (100 mM, pH 7.3), in 
which they were dissolved at the concentration of 30 μM for CD analysis. The spectra 
showed two negative bands at 222 nm (amide n–π∗ transition) and 204 nm (amide π–π∗ 
transition) and a positive one near 190 nm, with a crossover at 195-197 nm (Figure 7A). 
Secondary structure element composition was estimated by using the algorithm Contin [15] 
(Table 2), which indicated the presence of similar amounts of α-helix and β-sheet structures 
(the α/β ratios were ~1 for II.5 and II.7, and 0.6 for II.6). This suggests that these peptides 
were prone to aggregate, which was also supported by the observation that the CD spectra 
recorded at the concentrations of 30 and 100 μM were characterized by different intensities 
(the more concentrated sample gave a less intense CD signal). The conformation of peptides 
II.5-7 was not only concentration-dependent, but also time dependent; indeed, aging of II.5 
and II.6 favored the α-helix at the expense of the β-sheet structure, whereas aging of II.7 
increased the β-sheet structure at the expense of the α-helix (Figure 7B).  
 
 
Figure 7: CD spectra of peptides II.5-7 at the concentration of 30 μM in phosphate buffer (100 mM, pH 7.3): 
(A) fresh and (B) one-day-old samples. 
 
The weak helix character of the Id2 fragments II.5-6 is not very surprising, as they contain 
only part of the HLH fold (helix-2 with or without the loop); instead, it was surprising to see 
that peptide II.7, although spanning the complete HLH motif, was not able to adopt a stable 
helix conformation. Of course, modification of helix-1 by replacing Cys-42 with Ser might 
have affected the stability of the HLH fold; however, this cannot explain the aggregation 
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propensity that was observed not only for peptide II.7, but also for peptides II.5-6 that lack 
helix-1. Probably, as all three peptides shared the flanking residues C-terminal to helix-2, 
which were also present in the poorly soluble and aggregation-prone peptide II.3, it is likely 
that the common tendency of these four Id2 fragments to aggregate arise from such region. 
 
Table 2: Conformational properties of the synthetic Id2 C-terminal fragments 
No Number 
of 
residues 
R 
valuea 
Secondary structure element by Contin (%) b 
   Helix 
(Number 
of 
residues) 
β- 
sheet 
Turns Un- 
ordered 
II.5 50 0.70 23 (12) 20 23 34 
II.6 60 0.72 16 (10) 27 21 36 
II.7 75 0.71 21(16) 23 24 32 
a The R value is defined as the ratio between the CD intensities of the amide bands n-π* and π−π*. b 
The CD spectra of the 30 µM samples were analyzed by using the online server Dichroweb [16] 
       
 
 
II.3.2  Peptides related to the Id2 HLH motif 
 
The Id2 HLH motif 36-76 has been previously investigated by CD spectroscopy in 
phosphate buffer (100 mM, pH 7.3), and it has been shown to adopt a helical conformation 
that is stable also in the presence of high concentrations of guanidine hydrochloride (up to 4 
M) [14]. Moreover, the CD spectrum was characterized by an R value >1. In this work the 
Id2 HLH analogue II.12 was prepared by replacing the sulfur-containing residues Met and 
Cys with Nle and Ser, respectively. These substitutions have the advantage to avoid 
problems related with peptide oxidation; moreover, as they are highly conservative, no 
significant conformational changes were expected. Instead, the CD spectrum of the three-
point mutated HLH sequence was found to be less intense than that of the native motif, and 
the amide π–π∗ band was slightly blue-shifted. In addition, the R value became <1. Based 
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on the CD data reported in Figure 8, helical contents of 86% for the native and of 48% for 
the mutated HLH peptide were estimated with the algorithm Contin [15] (Table 3). These 
results suggest that the Cys and/or Met side chains are important for the HLH fold, and even 
subtle substitutions are badly tolerated. Thus, peptide II.12 is not a suitable candidate to be 
used in place of the native sequence for further conformational analyses. 
 
 
 
Figure 8: CD spectra of peptides II.10 and II.12 at the concentration of 30 μM in phosphate buffer (100 mM, 
pH 7.3), as fresh and one-day old samples. 
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Table 3: Conformational properties of the synthetic peptides related to the Id2 HLH region 
No Number 
of 
residues 
R 
valuea 
Secondary structure element by Contin (%) b 
   Helix 
(Number 
of 
residues) 
β- 
sheet 
Turns Un- 
ordered 
II.10 41 1.3 86 (35) 0 8 6 
II.12 41 0.96 48 (20) 9 21 22 
a The R value is defined as the ratio between the CD intensities of the amide bands n-π* and π−π*. b 
The CD spectra of the 30 μM samples were analyzed by using the online server Dichroweb [16]. 
       
 
 
In contrast to the one-point mutated HLH sequences conjugated to the Id2 C-terminal region 
II.7, the isolated HLH motifs of peptides II.10 and II.12 were found to be stable upon 
aging, with only a moderate increase in the intensity of the CD band corresponding to the 
amide π–π∗ transition (Figure 8). This observation again underlines the negative impact of 
the C-terminal extension on the folding and stability of the adjacent HLH region.  
The Id2 HLH motif contains three tyrosine residues, two of them, Tyr-43 and Tyr-71, 
are conserved within the Id family, whereas the third one, Tyr-37, is found only in Id1 and 
Id2. In order to investigate the importance of these positions for the HLH fold, analogues of 
the native sequence II.10 were synthesized (II.13-15), each containing two Phe→Tyr 
mutations. A significant reduction of the intensity and of the R value as well as a slight blue 
shift could be observed for the CD curves of the mutated peptides in comparison to the one 
of the native sequence II.10 (Figure 9). In particular, Tyr-43 and Tyr-71 were found to be 
structurally more important than Tyr-37, as indicated by the higher loss of CD intensity for 
peptides II.14-15 than for peptide II.13 (Figure 9). These data reveal that the tyrosine side 
chains are likely to be involved not only in hydrophobic contacts through the phenyl ring 
but also in hydrogen bonds through the OH group. 
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Figure 9: CD spectra of peptides II.10, II.13, II.14 and II.15 at the concentration of 100 μM in phosphate 
buffer (100 mM, pH 7.3) 
 
Further, to investigate whether both the N- and C-terminal helices of the HLH motif 
displayed similar intrinsic helix propensity, the CD spectra of the corresponding peptides 
II.9 (helix-1) and II.8 (helix-2) were recorded in phosphate buffer. The presence of an 
ordered conformation was found for helix-2 (II.8), whereas a disordered structure was 
found for helix-1 (II.9) (Figure 10 and Table 4). This suggests that the intrinsic helix 
propensity of helix-2 is much higher than that of helix-1. However, the conformational 
stability of helix-2 was concentration dependent, suggesting that a favorable intermolecular 
helix-packing, presumably through their hydrophobic faces, occurs by increasing the 
peptide concentration.  
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Figure 10: CD spectra of peptides II.8 (220 μM) and of peptide II.9 (180 μM) in phosphate buffer (100 mM, 
pH 7.3). 
 
 
Table 4: Conformational properties of the synthetic Id2 helix-1 (II.9) and helix-2 (II.8). 
No Number 
of 
residues 
R 
valuea 
Secondary structure element by Contin (%) b 
   Helix 
(Number 
of 
residues) 
β- 
sheet 
Turns Un- 
ordered 
II.8 17 0.87 61 (10) 6 1 32 
II.9 17 0.3 0 6 10 84 
a The R value is defined as the ratio between the CD intensities of the amide bands n-π* and π−π*. b 
The CD spectra were analyzed by using the online server Dichroweb [16]. 
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II.3.3  Noncovalent interactions between the Id2 N-terminus and the HLH 
containing peptides. 
 
The Id2 N-terminal fragment 1-35 (II.16) has been shown to adopt an unordered 
conformation in phosphate buffer [14]. However, when it was mixed with the native HLH 
motif (II.10) in a 1:1 ratio, the CD spectrum was characteristic of an α-helix and the 
intensity of the two minima at 222 and 206 nm was higher than the arithmetic sum of the 
intensities of the two separated fragments (Figure 11A). This indicates that an interaction of 
the N-terminus with the HLH fold could be detected, which apparently led to helix 
stabilization in the complex and was maintained also upon aging. 
When the experiment described above was carried out using the segment 36-110 (II.7) 
instead of the HLH motif (II.10), the CD spectrum of the mixture was less intense than the 
sum of the spectra of the two separated fragments (Figure 11B), suggesting an increase in β-
sheet structure at the expense of α-helix upon mixing. However, such changes seemed to be 
reversible, as the CD spectrum of the one-day-old mixture gained intensity and was close to 
the sum of the CD spectra of the two individual components (Figure 11C). Presumably, the 
increased tendency of peptide II.7 to self-aggregate became predominant, thus reducing the 
possibility of interaction with the N-terminus. The different effect of the N-terminus on the 
HLH motif alone and conjugated to the C-terminal tail 77-110 might reflect the different 
stability of the HLH fold; indeed, only in the former case the HLH domain was well-
structured, whereas it was not well-defined in the latter case, as it was discussed above 
about the conformational properties of peptides II.10 and II.7. This would imply a specific 
interaction pattern of the N-terminus with the folded HLH region, whereas the interaction 
would be mostly unspecific in the case of a partially unfolded HLH motif. 
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Figure 11: CD spectra of equimolar mixtures of the N-terminal sequence (II.16) with (A) the native HLH 
motif (II.10) and (B-C) the long fragment II.7. Each component in the mixture was at the concentration of 30 
μM. The CD spectra of the individual peptides (30 μM) and their arithmetical sum are also shown. 
 
 
 
II.4  Native chemical ligation approach for the synthesis of Id2 large fragments 
 
Native chemical ligation (NCL) [4] is a powerful tool in protein chemistry to prepare 
proteins of small to medium size by coupling unprotected peptides through an amide bond, 
usually under aqueous buffer conditions. The amide bond can be formed when the C-
terminal fragment possesses an N-terminal cysteine, and the N-terminal fragment is 
synthesized as C-terminal thioester (Figure 12). The ligation consists of a chemoselective 
capture between the thioester and the thiol function of the cysteine, followed by a 
spontaneous intramolecular rearrangement to give the desired amide bond.  
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Figure 12: A schematic representation of native chemical ligation [4] between two unprotected peptides in 
aqueous buffer solution. 
 
Because of the difficulties encountered during the syntheses of large Id2 analogues 
discussed above, the possibility to use the native chemical ligation was considered. A first 
trial was focused on the full-length C-terminus 77-134. As the only natural cysteine residues 
in this region is Cys-133 preceding the C-end, the introduction of an unnatural cysteine was 
necessary. Thus, the N-terminal cysteine-containing peptide component for NCL was [Cys-
98]-(98-134)-Id2 (II.17), in which the native Ala-98 was substituted with Cys. The 
synthesis was performed by stepwise solid-phase methodology starting from the Wang 
resin, and the obtained crude product was purified by preparative HPLC (Table 5). 
 
Table 5: Analytical data of the Id2 peptide analogues for NCL. 
No Chain length MWcalc (Da) MWfound (Da) 
tR (min) 
II.17 [C-98]-(98-134) 3944.5 3947.8 19.6 
II.18 Ac-(77-97)-SBn 2492 2495 11.1 
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Instead, the peptide thioester containing the Id2 sequence 77-97 was obtained in three steps 
(Scheme 2): first, the fully-protected peptide acid was synthesized by stepwise solid-phase 
methodology starting from 2-chloro-tritylchloride resin, and then it was converted in 
solution into a C-terminal thioester that was finally fully-deprotected to give II.18 [17].  
 
 
Scheme 2: Synthesis of the peptide thioester II.18 (PG: protecting group).  
 
 
 
 
 
Due to the high homogeneity of the product after the last step (Figure 13 and Table 5), it 
could be directly used for the NCL experiment, without any further purification. 
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Figure 13: HPLC profile of the crude peptide thioester II.18.  
 
 
Peptides II.17-18 were dissolved in phosphate buffer (100 mM, pH 7.3) containing TFE to 
increase the peptide solubility and guanidinium chloride (6 M) as denaturing agent. Sodium 
thiophenolate was used in catalytic amount to promote the transthioesterification. The 
reaction mixture was stirred at room temperature and monitored by HPLC. Unfortunately, 
the formation of the ligation product was found to run slowly and with unsatisfactory yields. 
Presumably, the aggregation propensity generally observed for sequences related to the Id2 
C-terminal domain compromised the efficiency of the ligation.  
 
 
II.5  Conclusions 
 
The Id2 protein is believed to be a promising target for tumor therapy, especially for 
neuroblastoma, where it has been shown to inhibit the function of pRb [18]. Therefore, both 
biochemical and conformational studies of Id2 are important to understand the mechanism 
of action and to develop chemical tools to block the Id2-pRb interaction. Synthetic peptides 
derived from amino acid replacement and N-/C-end truncation of Id2 are useful to study the 
importance of different parts of the sequence on the conformation. Here, we have reported 
on a series of Id2 analogues with variable length, which were prepared by stepwise SPPS 
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using Fmoc chemistry. The synthesis of the C-terminal domain was found to be difficult and 
to strongly vary with the truncation point. Moreover, a general poor solubility under 
physiological conditions as well as a propensity to self-aggregate was observed for Id2 
fragments containing part of the C-terminus.  
The Id2 HLH region was found to be very sensitive to amino acid substitutions: even 
conservative mutations like Nle/Met, Ser/Cys or Phe/Tyr were not-well tolerated. Also the 
presence of the domain immediately following the C-terminal helix-2 seemed to strongly 
alter the conformational properties of the HLH fold. 
All together, these results suggest that the three main subdomains of Id2, the N-terminus, 
the HLH motif and the C-terminus, play a role during protein folding and modulate the 
dimerization profile of Id2 with the related bHLH factors and the members of the Rb family.  
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III. A short Id2 protein fragment containing the nuclear export signal 
forms amyloid-like fibrils [1] 
 
 
III.1  Introduction 
 
Whereas the HLH motif in all four Id proteins seems to have predominantly a 
structural function, the role of the N- and C-terminal regions is not yet completely 
understood: it is known that phosphorylation of Ser-5 modulates the inhibitory activity of 
Id2 and Id3 [2, 3], and that the N-terminus of Id2 is necessary for ubiquitination [4]. 
Moreover, the N-terminus of Id2 can induce apoptosis independently of the HLH 
dimerization motif [5]. Recently, Kurooka and Yokota have shown that the HLH region of 
Id2 is required for the protein nuclear localization, whereas residues 103-119 in the central 
part of the C-terminus are necessary for the localization of the protein in the cytoplasm [6]. 
They also demonstrated that the isolated 17-residue long Id2 fragment displays nuclear 
export activity when conjugated to other proteins. Indeed, the sequence 106-115 has been 
identified as nuclear export signal (NES), in which Leu-106, Ile-110, Leu-113, and Leu-
115 are the key residues. An additional NES sequence is present in the helix-2 (residues 65-
75): this is conserved among the Id family members but is not functionally active in Id2 [6]. 
While investigating synthetic peptides related to the C-terminal domain of the Id2 
protein, we found that the fragment 99-134 was soluble and unstructured in phosphate 
buffer, whereas the fragment 77-124 was insoluble under the same conditions (Figure 1) [7, 
8]. Apparently, the different behavior of these two peptides, which share the same NES 
segment, is dictated by the neighboring regions. However, as the isolated Id2 NES is 
functional, we were wondering whether it adopts a preferred conformation or is rather 
flexible. Thus, we have undertaken the following study to elucidate the structural features 
of short synthetic peptides based on the Id2 NES sequence. 
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Figure1: Schematic representation of the full-length Id2 protein and of the synthetic fragments reproducing 
the N-terminus, the HLH motif, and parts of the C-terminus. The gray bars represent the two NES sequences; 
the motif 103-119 is required for the Id2 nucleo-cytoplasmic transport, whereas the motif 65-75 is inactive. 
The key residues of the C-terminal NES are underlined. 
 
 
III.2  Synthesis and conformational characterization of Id2 analogues containing 
the C-terminal NES sequence 
 
Kurooka and Yokota have identified the active NES of Id2 in the fragment 103-119 
[6]. However, Glu-119 is not a good starting point for the synthesis of Id2 analogues, as 
already discussed in chapter II [7], and it was thus chosen to study the longer fragment 103-
124 (peptide III.1, Table 1). This was found to be easily accessible by SPPS, but displayed 
the disadvantage of being insoluble in water. For this reason, the CD spectra of III.1 were 
recorded in methanol or TFE and upon addition of up to 50% water (at higher water 
percentages there was instantaneous peptide precipitation). In methanol, the NES sequence 
adopted a β-sheet structure, as indicated by the negative CD band at 214 nm and the 
positive one at 193 nm, with a crossover at 202 nm (Figure 2A). Upon water addition, there 
was a significant decrease in the CD intensity, which should be attributable to the formation 
of oligomers stabilized by hydrophobic interactions. In contrast, a helix conformation was 
induced in TFE, which remained stable upon addition of up to 50% water (Figure 2B). 
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Table 1: Synthetic peptides containing the functionally active NES region of Id2 
No. Sequence a MWcalc 
(Da) 
MWfound 
(Da) b 
tR 
(min) c 
III.1 L103TTLNTDISILSLQASEFPSEL124 2432 2343 24.0 
III.2 KKKX-L103TTLNTDISILSLQASEFPSEL124 2930 2931 21.5 
III.3 L103TTLNTDISILSLQASEFPSEL124-XKKK 2930 2932 21.1 
III.4 XKKK-L103TTLNTDISILSLQASEFPSEL124 2930 2935 17.2 
III.5 L103TTLNTDISILSLQASEFPSEL124-KKKX 2930 2933 18.8 
a The sequences are N-terminally acetylated and C-terminally amidated (X = Ahx). b The 
masses [M+H]+ were measured by MALDI-ToF-MS. c The retention times tR refer to the HPLC 
runs on a reverse-phase C18 column, with the binary system (A) 0.012% TFA in water and (B) 
0.01% TFA in acetonitrile (gradient: 10-70% B over 40 min). 
 
 
 
Figure 2: CD spectra of peptide III.1 at the concentration of 50 μM (A) in methanol/water or (B) in 
TFE/water. 
 
In order to improve the water solubility of peptide III.1 or at least to slow down its 
precipitation from alcohol/water, we decided to modify the sequence by increasing the 
number of positively charged residues, an approach that has been successful to stabilize 
amyloidogenic peptides in solution like PrP 174-195 [9]. As such modification should 
obviously not affect the conformation significantly, we chose the motif (Lys)3-Ahx to be 
coupled to the N-terminal residue 103 (peptide III.2, Table 1), or to the C-terminal residue 
124 (peptide III.3, Table 1). Besides three ammonium ions, this motif displays the 6-
 Short Id2 C-terminal peptide forms amyloid-like fibrils 
 
46
aminohexanoyl unit (Ahx) as a spacer between the basic moiety and the NES region, which 
should also reduce the risk of influencing the conformation of the latter. Although both 
analogues were still insoluble in water, they could be dissolved in methanol/water or 
TFE/water mixtures containing up to 80% water. Moreover, the results of the turbidity 
assays showed that the solution form of peptide III.3 was much more stable than that of 
peptide III.2 (Figure 3).  
 
 
 
 
Figure 3: Time-dependent appearance of turbidity in solutions of peptides III.1-3 (50 μM in methanol/water 
mixtures). 
 
 
The effect of N- or C-terminal modification of peptide III.1 on its conformation was 
investigated by CD spectroscopy. In methanol peptide III.2 was characterized by a very 
intense β-sheet-like CD curve (Figure 4A). It is plausible to assume that the β-strands were 
in an antiparallel arrangement, which would allow favorable electrostatic interactions 
involving the basic N-terminal lysine residues and the C-terminal glutamic acid residues 
(Glu-119/-123) (Figure 5). Additionally, aromatic-cation interactions between Phe-120 and 
the lysine side chains might also have a stabilizing effect [10]. As observed above for 
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peptide III.1, the intensity of the CD spectra of III.2 decreased in methanol/water mixtures; 
however, unlike III.1, III.2 was probably displaying a helical intermediate at the 
methanol/water ratios 80:20 and 60:40, as indicated by the appearance of a negative band 
close to 207 nm. This band disappeared at lower methanol/water ratios, suggesting that the 
helix conformer has low stability, probably because of unfavorable contacts between the 
poles of the helix dipole and the positively or negatively charged residues adjacent to the 
N- and C-ends, respectively. In contrast, increasing the water content in the solvent mixture 
favored the formation of β-sheet aggregates stabilized by hydrophobic interactions. 
Importantly, the CD spectrum of peptide III.2 in methanol/water 40:60 or 20:80 was 
similar in shape and intensity to that of peptide III.1 in methanol, indicating that the 
analogue III.2 was structurally close to the native fragment 103-124, but it had the 
advantage of requiring smaller amounts of organic solvent to be dissolved and remain in 
solution for a long period. Also in TFE peptide III.2 behaved like peptide III.1, building an 
α-helix that was stable upon addition of up to 60% water (Figure 4B). At higher water 
percentage, peptide III.2 underwent a conformational change from α-helix to β-sheet, 
which was not observed for peptide III.1 (Figure 2B), thus showing its strong tendency to 
adopt a β-sheet structure even in the presence of a well-known α-helix-stabilizing solvent 
like TFE. 
Surprisingly, when the motif (Lys)3-Ahx was conjugated to the C-terminus of the 
sequence 103-124, the obtained peptide III.3 (Table 1) adopted a helical conformation both 
in methanol and in TFE, which was partially destabilized upon water addition (Figure 4C-
D). The helix preference of III.3 might reflect a favorable interaction between the negative 
pole of the helix dipole and the positively charged residues at the C-end. Thus, modifying 
the NES region at the C-terminus was structurally not equivalent to modifying it at the N-
terminus, as only in the latter case the peptide was allowed to form a  β-sheet structure. One 
reason might be the generation of unfavorable electrostatic interactions upon peptide-chain 
alignment, thus preventing the formation of β-sheets. 
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Figure 4: CD spectra of peptide III.2 at the concentration of 50 μM (A) in methanol/water and (B) in 
TFE/water, and of peptide III.3 at the concentration of 50 μM (C) in methanol/water and (D) in TFE/water. 
 
 
 
Figure 5: Proposed antiparallel alignment of β-strands of III.2. 
The possibility that peptides III.2 and III.3 could interact in solution was investigated 
by CD spectroscopy, in methanol and in water with 20% methanol (Figure 6A-B). As 
already described above (Figure 4A), in both cases III.2 alone shows a β-sheet structure, 
whereas III.3 displays a stable α-helix in methanol which undergoes a conformational 
transition to 310-helix [11] upon water addition (Figure 4C). The equimolar mixture of the 
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two peptides in both conditions was found to behave more like III.3 alone than III.2 alone, 
showing a well-defined helix character, especially in methanol. Moreover, the CD curve of 
the mixture was not only characteristic of a helix but was also more intense than the curve 
expected in the case of an equimolar mixture of non-interacting species in the region 
between 202 and 230 nm.  
 
 
 
Figure 6: CD spectra of peptides III.2 and III.3, and of their equimolar mixture (A) in methanol and (B) in 
methanol/water 20:80. In each sample the overall peptide concentration was 50 μM. 
 
 
The results of this experiment suggest that an interaction between the α-/310-helical peptide 
III.3 and the β-sheet peptide III.2 can occur, and that the hetero-association not only 
induces a helical conformation at the expense of the β-sheet one, but also improves the 
helicity in comparison to the self-association (Scheme 1).  
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Scheme 1: Suggested mechanism of interaction between the β-sheet peptide III.2 and the α-helix peptide 
III.3 (the black thick arrow represents a β-strand, whereas the yellow cylinder represents a α-helix. The red 
arrow represents the helix dipole. Blue, red and white spheres represent lysine, glutamic acid and 
phenylalanine, respectively). Although an antiparallel helix packing is usually stabilized by a favorable 
interaction of the helix dipoles, a parallel helix packing can not be excluded.  
 
 
 
 
To investigate the role of the spacer moiety connecting the three lysine residues with 
the target peptide, we also synthesized two analogues of III.2 and III.3, in which the Ahx 
unit was shifted before or after the lysine residues, respectively (III.4 and III.5, Table 1). 
Both peptides showed helix propensity that was higher for peptide III.5 than for peptide 
III.4, thus indicating that positively charged residues improved the helix stability more 
efficiently while located at the C-end rather than at the N-end (Figure 7). However, these 
results also show that the presence of a spacer between the lysine residues and the target 
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peptide chain can reduce the impact of the lysine tag on the structural properties of the 
target peptide chain. 
 
 
 
Figure 7: CD spectra of (A) III.4 and (B) III.5 at the concentration of 50 μM in methanol/water. 
 
 
Based on the CD study of peptides III.1-5, we conclude that the isolated Id2 fragment 
containing the NES domain can form stable β-sheets or α-helices depending on the solvent. 
Among the lysine-tagged analogues, only the N-terminally modified one containing a 
spacer between the lysine-tag and the peptide chain (III.2) presented conformational 
properties very similar to those of the unmodified peptide, whereas the N-terminally 
modified one lacking the spacer (III.4) as well as the C-terminally modified ones (III.3 and 
III.5) lost the ability to form a β-sheet structure. 
 
 
III.3  Synthesis and conformational characterization of Id2 analogues containing 
the NES sequence in the helix-2 
 
A putative NES sequence spans a leucine-rich region in the helix-2. The helix-2 of 
Id2 (peptide II.8) has been shown to be easy to synthesize and to adopt an α-helical 
conformation depending on the peptide concentration. [7]. We have synthesized helix-2 
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peptide analogues containing the motif (Lys)3-Ahx coupled to the N-terminal residue 60 
(peptide III.6, Table 2), or to the C-terminal residue 76 (peptide III.7, Table 2) to 
investigate whether this motif can affect the structural features of a helix preferring 
sequence. 
 
Table 2: Synthetic peptides containing the putative NES sequence in the helix-2 of Id2. 
No. Sequence a MWcalc 
(Da) 
MWfound 
(Da) b 
tR 
(min) c 
II.8 S60KMEILQHVIDYILDLQ76 2099.5 2100 21.5 
III.6 KKKX-S60KMEILQHVIDYILDLQ76 2597.2 2599.5 17.5 
III.7 S60KMEILQHVIDYILDLQ76-XKKK 2597.2 2600.7 18.8 
a The sequences are N-terminally acetylated and C-terminally amidated (X = Ahx). b The 
masses [M+H]+ were measured by MALDI-ToF-MS. c The retention times tR refer to the HPLC 
runs on a reverse-phase C18 column, with the binary system (A) 0.012% TFA in water and (B) 
0.01% TFA in acetonitrile (gradient: 10-70% B over 40 min). 
 
 
The three compounds were dissolved at the concentration of 50 μM in phosphate buffer 
(100 mM, pH 7.2) and analyzed by CD spectroscopy (Figure 8). As expected, peptide II.8 
assumed a flexible conformation at this concentration, giving a CD spectrum characterized 
by a negative band at 201 nm followed by a shoulder at 225 nm. 
When the motif (Lys)3-Ahx was coupled to the N-terminal residue of II.8, the resulting 
peptide III.6 was helical, with an intense CD spectrum characterized by two negative bands 
at 206 nm and 221 nm (R = 0.85), and an intense positive band below 195 nm with a 
crossover at 198 nm. When the motif (Lys)3-Ahx was coupled to the C-terminal residue of 
II.8, the resulting peptide III.7 displayed a CD curve with a blue-shifted minimum at 204 
nm, a shoulder near 222 nm (R = 0.74), but no maximum below 200 nm. This shape reflects 
the presence of the both α- and the 310-helix types. Therefore, upon these conditions 
peptide III.7 probably represents a conformational intermediate state between the mostly 
flexible state of peptide II.8 and the α-helix folded state of peptide III.6, which is likely to 
be characterized by the presence of a nascent helix, like the 310-helix [11].  
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Figure 8: CD spectra of peptides II.8, III.6 and III.7 (50 μM in 100 mM phosphate buffer, pH 7.2). 
 
The α-helix propensity of peptides II.8 and III.7 could be enhanced by addition of 
methanol to the phosphate buffer (Figure 9, panels A and C). Indeed, increasing the amount 
of organic solvent was accompanied by an increase in the intensity of a α-helix-like CD 
curve, thus indicating an increase in the helix content. In contrast, addition of up to 40% 
methanol to the buffer solution of peptide III.6 caused a destabilization of the α-helical 
structure, which, however, was overcome at higher methanol contents (Figure 9B). 
Interestingly, the intensity of the CD spectrum of III.6 at the highest methanol content 
investigated (80%) was inferior to that obtained for peptides II.8 and III.7, which might be 
attributable to the presence of a fraction of β-sheet aggregates. 
All together, these results suggest that the N-terminal Lys-tag stabilized the α-helix 
structure of the target peptide II.8 under physiologic conditions, whereas the C-terminal 
Lys-tag stabilized the 310-helix type. However, in the presence of high contents of 
methanol, the C-terminal Lys-tag was found to be superior in stabilizing the α-helix, as 
indicated by the high intensity of the CD band below 200 nm for peptide III.7 (Figure 8C). 
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Figure 9: CD spectra of helix-2 peptide analogues (50 μM) in methanol/phosphate buffer mixtures. (A) II.8, 
(B) III.6 and (C) III.7. 
 
 
III.4  Characterization of the insoluble form of the C-terminal NES region of Id2 
 
Beside the conformation of the Id2 NES region in solution, we also wanted to 
characterize its insoluble form. To do that, we analyzed at first the morphology of the 
aggregates formed by the NES peptide III.1 and by the variant III.2 by transmission 
electron microscopy (TEM). Two samples of III.1 were prepared in methanol and in 
methanol/water 80:20 (the high alcohol content was necessary to slow down the 
precipitation), while III.2 was dissolved in methanol/water 20:80 because of its improved 
hydrophilic character. After incubation for ten days or one month, the obtained suspensions 
 Short Id2 C-terminal peptide forms amyloid-like fibrils 
 
55
were stained with a 2% aqueous solution of phosphotungstic acid (pH 7.2) and analyzed by 
TEM. After ten days, peptide III.2 had formed fibrils with widths of 6-8 nm and lengths 
ranging from 60 to 200 nm (Figure 10A). Fibrils characterized by a banding pattern with 
alternating light and dark zones of 8 and 3 nm heights, respectively, were also visible 
(Figure 10B). Instead, isolated or assembled spherical particles (~10 nm in diameter) as 
well as amorphous material were present in the sample of peptide III.1 containing 80% 
methanol (Figure 10C). Similar isolated spheres were detected for peptide III.1 in 
methanol, although in this case the absence of water had strongly lowered the formation of 
deposits (Figure 10D).  
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Figure 10: TEM images of the insoluble aggregates formed by peptides III.1 and III.2 after ten days. (A) 
Fibrils obtained by a 50 μM solution of peptide III.2 in methanol/water 20:80; magnification grade of 20000. 
(B) Fibrils obtained by a 50 μM solution of peptide III.2 in methanol/water 20:80; magnification grade of 
40000 (C) Spherical particles and amorphous material obtained by a 50 μM solution of peptide III.1 in 
methanol/water 80:20; magnification grade of 20000. (D) Spherical particles and amorphous material 
obtained by a 50 μM solution of peptide III.1 in methanol; magnification grade of 40000. The staining was 
performed by using 2% aqueous solution of phosphotungstic acid (pH 7.2). 
 
 
As it is known that β-sheet fibrils like those formed by amyloid peptides and proteins 
bind Thioflavin T (ThT) [12], we investigated whether the Id2 NES aggregates were also 
displaying this property. Indeed, by analyzing the ten-day-old samples of peptides III.1 and 
III.2, we found that only peptide III.2 increased the fluorescence emission of ThT at 484 
nm after excitation at 446 nm (Figure 11). 
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Figure 11: ThT assay. Fluorescence of ThT alone (5 μM in methanol/water 20:80) or mixed with a fibrillar 
sample of peptide III.2 (50 μM in methanol/water 20:80). In the latter case, 25 μL of a ten-day-old peptide 
suspension were added to the ThT solution, which was then excited at 446 nm.  
 
After one month, the peptide III.2 fibrils reached up to 10 nm thickness and up to 1 
μm length (Figure 12A-B), while peptide III.1 precipitated abundantly from methanol with 
and without 20% methanol, forming highly dense deposits which appeared to be mostly 
amorphous (Figure 12C-D).  
To control if the negative staining procedure could affect the morphology of the solid 
aggregates, the same one-month-old samples described above were stained with a 2% 
aqueous solution of uranyl acetate (pH 4.1). In the case of peptide III.2, besides the already 
observed fibrils, well-defined spherical particles with diameters in the range of 12-30 nm 
were observed (Figure 13A). Such granules were also characteristic of peptide III.1 in 80% 
methanol (Figure 13B), whereas the sample in methanol presented compact deposits of 
both fibrillar and amorphous material (Figure 13C-D). 
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Figure 12: TEM images of the insoluble aggregates formed by peptides III.1 and III.2 after one month. (A-
B) Fibrils obtained by a 50 μM solution of peptide III.2 in methanol/water 20:80. (C) Spherical particles and 
amorphous material obtained by a 50 μM solution of peptide III.1 in methanol/water 80:20. (D) Spherical 
particles and amorphous material obtained by a 50 μM solution of peptide III.1 in methanol. The staining was 
performed by using 2% aqueous solution of phosphotungstic acid (pH 7.2); the magnification grade is 20000 
for all four pictures. 
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These results suggest that the aggregates of peptides III.1 and III.2 are pH sensitive: 
in particular, the fibrils of peptide III.2 seem to be unstable at low pH, where the formation 
of spherical aggregates is favored. This would be consistent with the antiparallel β-sheet 
model described above (Figure 5), stabilized by electrostatic interactions between the 
positively charged lysine side chains and the negatively charged side chains of the C-
terminal glutamic acid residues. Such favorable interactions would be partially lost at pH 
values near 4, thus destabilizing the β-sheet aggregates (Figure 14). In the case of peptide 
III.1, the morphologies of the aggregates shown after acidic staining appeared more 
ordered than those shown after neutral staining: indeed, well-defined granular deposits and 
clumped fibrils were found for the sample in 20% water and in methanol, respectively. 
Thus, it is likely that the staining procedure performed at neutral pH partly converted the 
ordered aggregates to amorphous material, due to the increase in the peptide net charge 
after deprotonation of the aspartic and glutamic acid residues. 
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Figure 13: TEM images of the insoluble aggregates formed by peptides III.1 and III.2 after one month. (A) 
Fibrils and spherical particles obtained by a 50 μM solution of III.2 in methanol/water 20:80; magnification 
grade of 40000. (B) Spherical particles obtained by a 50 μM solution of III.1 in methanol/water 80:20; 
magnification grade of 40000. (C-D) Clumped fibrils and amorphous material obtained by a 50 μM solution 
of III.1 in methanol; magnification grade of 10000 and 20000, respectively. The staining was performed by 
using 2% aqueous solution of uranyl acetate (pH 4.1). 
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Figure 14: Proposed antiparallel alignment of III.2 β-strands in the fibril. 
 
For comparison, also peptide III.3 was analyzed by electron microscopy. A sample of 
III.3 in methanol/water 20:80 was incubated for 14 days or one month, and the obtained 
suspensions were stained with a 2% aqueous solution of phosphotungstic acid (pH 7.2) and 
analyzed by TEM (Figure 15, panels A and C). Interestingly, already after 14 days 
incubation peptide III.3 was able to form mature long fibrils, characterized by a banding 
pattern with alternating light and dark zones of 6-9 nm and 5-6 nm width, respectively 
(Figure 15A). After one month, the fibrils grew further and formed compact assemblies 
(Figure 15C). Unlike the morphology of peptides III.1 and III.2, the one shown by the 
aggregates formed by peptide III.3 was not sensitive to the pH value of the staining 
procedure. As a matter of fact, the same type of fibrils was detected by staining with a 2% 
aqueous solution of uranyl acetate (pH 4.1) and with a 2% aqueous solution of 
phosphotungstic acid (pH 7.2) (Figure 15, panels B and D). 
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Figure 15: TEM images of the aggregates formed by III.3 from a 50 μM peptide solution in methanol/water 
20:80. (A) Fibrils obtained after 14 days incubation, staining with 2% aqueous solution of phosphotungstic 
acid (pH 7.2); magnification grade of 10000. (B) Fibrils obtained after 14 days incubation, staining with 2% 
aqueous solution of uranyl acetate (pH 4.1); magnification grade of 20000. (C) Fibrils obtained after one 
month incubation, staining with 2% aqueous solution of phosphotungstic acid (pH 7.2); magnification grade 
of 10000. (D) Fibrils obtained after one month incubation, staining with 2% aqueous solution of uranyl 
acetate (pH 4.1); magnification grade of 20000. 
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A proposed mechanism of fibril formation for the peptide III.3 is shown in Figure 16. 
An antiparallel organization of the helix monomers in a bilayer with a hydrophobic core 
and two polar surfaces might be stabilized by favorable interactions between the helix 
dipoles. In this model the flexible lysine-tags would lie at opposite sites of the bilayer.  
 
 
 
Figure 16: Proposed antiparallel alignment of III.3 helices in the fibril.  
 
Also an equimolar mixture of the peptides III.2 and III.3 in methanol/water 20:80 
was studied by electron microscopy. After incubation for 14 days or one month, the 
obtained suspensions were stained with a 2% aqueous solution of phosphotungstic acid (pH 
7.2) (Figure 17, panels A and C) or with a 2% aqueous solution of uranyl acetate (pH 4.1) 
(Figure 17, panels B and D) and analyzed. Fibrils with morphology similar to that of the 
aggregates formed by III.3 were observed. This is in agreement with the CD data obtained 
for the same mixture, which have been described above (Figure 6). Accordingly, hetero-
association of III.2 and III.3 is likely to improve helicity and helix stability and might lead 
to self-assembly with fibril formation, as proposed in Figure 18. 
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Figure 17: TEM images of the aggregates formed by an equimolar mixture of peptides III.2 and III.3 (50 μM 
in methanol/water 20:80). (A) Fibrils obtained after 14 days incubation, staining with 2% aqueous solution of 
phosphotungstic acid (pH 7.2). (B) Fibrils obtained after 14 days incubation, staining with 2% aqueous 
solution of uranyl acetate (pH 4.1). (C) Fibrils obtained after one month incubation, staining with 2% aqueous 
solution of phosphotungstic acid (pH 7.2). (D) Fibrils obtained after one month incubation, staining with 2% 
aqueous solution of uranyl acetate (pH 4.1). The magnification grade was of 20000 for all pictures. 
 
 
 Short Id2 C-terminal peptide forms amyloid-like fibrils 
 
65
 
 
Figure 18: Proposed antiparallel alignment between the peptides III.2 and III.3 in the fibril.  
 
 
III.5  Conclusions 
 
We have shown that the Id2 fragment 103-124 containing the leucine-rich active NES 
motif adopts a β-sheet structure in methanol/water, from which it aggressively precipitates 
in amorphous, spherical or fibril-like forms depending on the environment. We could also 
show that the conjugation of target peptides to lysine-tags at the N- or C-ends can affect the 
conformation, and that, consequently, a careful analysis on the structure of lysine-tagged 
peptides is required.  
Thus far, there is no evidence that the Id2 protein is subjected to 
oligomerization/aggregation in vivo; however, it is known that Id2 can form homodimers 
stabilized by an intermolecular disulfide bond involving the HLH residue Cys-42, and that 
the Cys-42/Ala mutation is deleterious for the Id2 activity [13]. Therefore, Id2 can undergo 
self-association, which might be a potential mechanism for auto-regulation or modulation 
of the inhibitory activity. Further studies are necessary to clarify whether the intrinsic 
propensity of the Id2 NES subdomain to aggregate has any significance for the folding and 
biology of this protein. 
 
 
 
 
 
 Short Id2 C-terminal peptide forms amyloid-like fibrils 
 
66
III.6  Literature 
 
1. Colombo, N., Schroeder, J., Cabrele, C. (2006) A short Id2 protein fragment 
containing the nuclear export signal forms amyloid-like fibrils, Biochem. Biophys. 
Res. Commun., 346, 182-187. 
2. Hara, E., Hall, M., Peters, G. (1997) Cdk2-dependent phosphorylation of Id2 
modulates activity of E2A-related transcription factors, Embo J.,. 16, 332-342. 
3. Deed, R.W., Hara, E., Atherton, G. T., Peters, G., Norton, J. D. (1997) Regulation 
of Id3 cell cycle function by Cdk-2-dependent phosphorylation, Mol. Cell Biol., 17, 
6815-6821. 
4. Fajerman, I., Schwartz, A.L., Ciechanover , A. (2004) Degradation of the Id2 
developmental regulator: targeting via N-terminal ubiquitination, Biochem. 
Biophys. Res. Commun., 314, 505-512. 
5. Florio, M., Hernandez, M. C., Yang, H., Shu, H. K., Cleveland, J. L., Israel, M. A. 
(1998) Id2 promotes apoptosis by a novel mechanism independent of dimerization 
to basic helix-loop-helix factors, Mol. Cell Biol., 18, 5435-5444. 
6. Kurooka, H., Yokota, Y. (2005) Nucleo-cytoplasmic shuttling of Id2, a negative 
regulator of basic helix-loop-helix transcription factors, J. Biol. Chem., 280, 4313-
4320. 
7. Colombo, N., Cabrele C. (2006) Synthesis and conformational analysis of Id2 
protein fragments: impact of chain length and point mutations on the structural 
HLH motif, J. Pept. Sci., 12, 550-558. 
8. Kiewitz, S.D., Cabrele, C. (2005) Synthesis and conformational properties of 
protein fragments based on the Id family of DNA-binding and cell-differentiation 
inhibitors, Biopolymers, 80, 762-774. 
9. Bosques, C.J., Imperiali. B. (2003) Photolytic control of peptide self-assembly. J. 
Am. Chem. Soc., 125, 7530-1. 
10. Ma, J.C., Dougherty, D.A. (1997) The Cation minus sign pi Interaction, Chem. 
Rev., 97, 1303-1324. 
11. Crisma, M., Formaggio, F., Moretto, A., Toniolo, C. (2006) Peptide helices based 
on alpha-amino acids, Biopolymers, 84, 3-12. 
 Short Id2 C-terminal peptide forms amyloid-like fibrils 
 
67
12. Le Vine 3rd, H. (1999) Quantification of β-sheet amyloid fibril structures with 
thioflavin T, Methods Enzymol., 309, 274-284. 
13. Liu, J., Shi, W., Warburton, D. (2000) A cysteine residue in the helix-loop-helix 
domain of Id2 is critical for homodimerization and function, Biochem. Biophys. 
Res. Commun., 273, 1042-1047. 
 
 
 Toward peptidomimetics as modulators of Id-protein-protein interaction 68
IV.  Toward peptidomimetics as modulators of Id protein-protein 
interactions 
 
 
IV.1  Introduction 
 
One of the major challenges in medical research is to understand how a protein 
correlates to a specific biological or pathological effect. Many cellular processes are 
regulated through protein-protein interactions: as a result of the central role of this 
mechanism, the aberrant or inappropriate formation of protein complexes can lead to 
pathological events. One example for that is provided by the Id proteins, as already 
reported in Chapter I. Indeed, these proteins act as dominant negative regulators of DNA 
transcription by forming heterodimers with ubiquitously as well as tissue-specifically 
expressed bHLH factors [1]. As increased Id protein activity has been observed in several 
cancer types, perturbation of the interaction between the Id proteins and their natural 
dimerization partners by using synthetic molecules might represent an interesting approach 
for anti-cancer therapy. Moreover, the fact that the Id proteins are present at high levels in 
tumor cells, whereas they are generally not found in healthy adult cells, offers the 
advantage of selectively distinguishing between pathological and physiological systems.  
There are different methods to understand the mechanisms of protein complex 
formation and to design new compounds that could interfere with it [2]. Computational 
approaches are a useful tool for the identification of small-molecule modulators of protein-
protein interactions. They have been successfully used, for example, to discover inhibitors 
of the formation of a complex between Bcl-2 and Bak, two proteins involved in the 
apoptotic process. A second possibility consists of the screening of chemical libraries. This 
approach led to the identification of inhibitors of Myc/Max dimerization [2, 3]. Myc and 
Max belong to the HLH family of transcription factors and have a leucine-zipper domain at 
their C-termini. Based on the crystal structure of the related Max/Max homodimer, it has 
been assumed that the Myc/Max heterodimer forms a parallel four-helix bundle by 
interaction of the respective HLH domains. The protein-protein interface is formed mostly 
by hydrophobic amino acid residues. Vogt and co-workers [3] performed a screening of 
 Toward peptidomimetics as modulators of Id-protein-protein interaction 69
several inhibitor candidates using fluorescence resonance energy transfer (FRET), and 
identified two compounds that were able to disrupt the formation of the complex (Figure 1). 
This was further confirmed in biological tests performed on chicken embryo fibroblasts, in 
which oncogenic c-Myc induced transformation was inhibited. 
 
 
 
Figure1: Small-molecule inhibitors of the Myc/Max dimerization [3]. 
 
Another approach to target protein assembly consists of the identification of peptides 
derived from the interface between interacting proteins, which are able to bind to one of the 
complex subunits in a competitive fashion. These peptides are subsequently “converted” 
into peptidomimetics by the incorporation of unnatural amino acids or other chemical 
modifications to improve their specificity and proteolytic stability. 
The field of the peptidomimetics is rapidly evolving because of their potential as precursors 
of efficient compounds that could lead to new therapeutically useful drugs. 
Peptidomimetics have some advantages as therapeutics in terms of pharmacokinetic 
properties, due to their major stability towards the hydrolytic activity of proteases. 
Moreover, the introduction of conformational restrictions can minimize the binding to non-
target proteins and enhance the selectivity for the desired one, while the increase in 
hydrophobicity can result in better transport properties through cellular membranes. 
Accordingly, methylation of the amide nitrogen enhances the hydrophobic character of the 
peptide backbone, but also changes the network of intra-molecular interactions. The role of 
the peptide backbone can be investigated by the introduction of amide bond isosteres, like 
the -CH2NH- or -CH2S- groups, while the insertion of a trans-olefin is the best way to 
maintain the planarity and rigidity of the amide bond (Figure 2) [4, 5]. 
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Figure 2: Examples of possible backbone modifications in the design of peptidomimetics.             
 
The most common strategy for the design of peptidomimetics is based on the 
substitution of native amino acid residues with unnatural ones. Also the introduction of D-
amino acids in bioactive sequences can positively affect the proteolytic stability and 
provide some oral bioavailabiliy [6]; additionally, it can lead to a stabilization of secondary 
structure motifs, in particular of turns [7-9]. As a matter of fact, the ability of a 
peptidomimetic to fold into an ordered structure is, indeed, an important prerequisite. 
Polymers of α-amino acids present a well-known set of secondary structures characterized 
by precise hydrogen bond patterns and torsional angles along their backbones (Figure 3). 
The α-helix is the most abundant helix conformation found in globular proteins. It consists 
of a spiral arrangement of the peptide backbone with 3.6 amino acids per wheel stabilized 
by hydrogen bonds between residues i and i+4. The 310-helix differs from the α-helix in the 
number of residues per wheel, which is 3.2, and in the hydrogen bonding pattern that 
involves residues i and i+3. Another common conformation in nature is the β-sheet that is 
formed by two neighboring polypeptide chains aligned in a parallel or antiparallel manner 
and stabilized by intermolecular hydrogen bonds [10]. 
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α-Helix
310-Helix
Antiparallel
β-sheet
 
 
Figure 3: The most common secondary structures found in peptides and proteins.  
 
The above mentioned secondary structure elements are connected in proteins by loops. 
They are important to change the direction of the backbone and are often involved in 
ligand-receptor recognition. Turns are classified according to the number of amino acids 
involved: for example, γ-turns are made of three residues, whereas β-turns are formed by 
four residues [11]. 
Many examples of synthetic amino acids as building blocks in bioactive sequences are 
known from literature [12-14]. A large number contain constraints that are important to 
rigidify the peptide structure. The application of synthetic building blocks to prepare 
analogues of the Id HLH motif and their conformational and pharmacological implications 
will be described in the following sections. 
 
 
IV.2  3-Carboxy-cyclopentylglycine (Cpg) as a tool for N-N linkage of peptides 
 
The non-proteinogenic amino acid 3-carboxy-cyclopentylglycine (Cpg) can be 
considered a conformationally restricted analogue of 2-amino-adipic and 2-amino-pimelic 
acid, two amino acids found in bioactive molecules, as well as a superior homologue of the 
natural α-amino acid Glu. Additionally, it also has the potential to be used as δ-amino acid, 
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while the presence of the two carboxylic groups connected by a chain of four carbon atoms 
allows this building block to be a tool for intra- or intermolecular crosslinking (Figure 4).  
 
 
 
Figure 4: The Cpg scaffold: the carboxylic groups are suitable for conjugation to the N-terminus of peptides, 
whereas the amino group can be masked with different protecting groups, but also conjugated to peptides or 
labeled with fluorophores.  
 
 
The synthesis of Cpg has been developed by Gelmi and co-workers [15]. Enantiopure 
(SRS)-Cpg and (RSR)-Cpg derive from a base-catalyzed retro-Claisen reaction on the β-
ketoester shown in Scheme 1, followed by chemo-enzymatic resolution performed on a 
semi-preparative scale using the acylase from Aspergillus melleus. 
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Scheme 1: Synthesis of the Cpg enantiomers [15]. 
 
 
 
 
The main structural and functional domain of the Id proteins consists of two 
amphipathic α-helices connected by a loop. As mentioned above, these connecting regions 
are important to determine the folding of a biomolecule and they can play a role in protein-
ligand and protein-protein interactions. In comparison to the helical regions, the loop of the 
Id proteins is much less conserved, although the ones of Id1 and Id2 present many 
similarities. The importance of the loop in the Id HLH folding has been investigated by its 
substitution with a C5-aliphatic chain [16]. CD spectroscopy analysis of these analogues 
has shown that they all dramatically lost helix content, with the Id3 HLH analogue being 
the only one to still contain some helical elements. This suggests that the Id loop plays a 
role in determining the correct orientation of the two flanking helices, thus favoring the 
folding and stability of this domain. 
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Starting from this observation, we were interested in the use of unnatural amino acids as 
loop surrogates, which should preferably stabilize a parallel arrangement of the two 
flanking regions, as it is suggested that the HLH motif of the Id proteins also displays a 
parallel helix packing, at least as heterodimer subunit. Loop-modified Id HLH peptides 
might be interesting models for the development of highly structured protein domains as 
well as of molecules interacting with the native HLH region of the Id proteins.    
The Cpg scaffold presents two carboxylic groups separated by four carbon atoms, 
three of them are constrained in a cyclopentyl ring (Figure 4). Hence, Cpg can be used as a 
linker between two peptide portions and tested as potential loop surrogate. However, a 
limitation of the presented Cpg scaffold is the lack of an orthogonal protection for the two 
carboxylic acids, which reduces its application to the synthesis of covalent homodimers. 
Nevertheless, we decided to explore this application and to prepare Cpg-linked dimers of 
peptides corresponding to the helix-2 of the Id HLH motif that is more conserved and has 
higher intrinsic helix propensity than helix-1. Preliminary studies to evaluate the suitability 
of Cpg as a building block for solid phase peptide synthesis have been done on its racemic 
mixture. This was coupled manually to a resin-immobilized peptide related to the helix-2 of 
Id1 (residues 91-101 or 91-106) (Scheme 2). Due to the tendency of Cpg to epimerize in 
the presence of bases, the coupling reaction was accomplished using only DIC and HOBT 
[17]. These base-free acylation conditions have been used for the syntheses of all Cpg-
containing peptides presented in this work (Figure 5). Unfortunately, the two diastereomers 
obtained for peptide IV.1 could not be separated by HPLC, which prevents the use of Cpg 
as a racemate for our scope. 
 
 
Scheme 2: Synthesis of a covalent dimer of the Id1 sequence 91-101. The yellow sphere represents the Rink 
amide resin (the Cpg building block was used as a racemate) 
 
 
 Toward peptidomimetics as modulators of Id-protein-protein interaction 75
IV.2.1  Synthesis of Id peptide dimers containing (SRS)-Cpg or (RSR)-Cpg 
 
A series of peptides analogous to IV.1 have been prepared using the enantiopure Cpg 
derivatives, as shown in Scheme 3. The Id fragments were first synthesized by automated 
stepwise solid phase synthesis, and their amino acid sequences are listed in Table 1. The 
quality of the assembled peptide chain was controlled by performing a small-scale TFA 
cleavage of the peptide from the solid support: the crude peptides were found to be highly 
homogeneous, with the exception of IV.4, derived from helix-2 of Id3, and of IV.5, derived 
from helix-1 of Id1. In the first case, a truncated peptide lacking a glutamine was present as 
side product, while in the second one there was a more complex mixture of undesired 
products. Therefore, IV.4-5 were not further used in this study. 
 
 
Scheme 3: Synthesis of Id peptide dimers containing Cpg in the SRS or RSR configuration. The peptide 
sequence (green colored) was anchored to the Rink amide resin (yellow sphere). 
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Table 1: Id sequences C-terminally anchored on Rink amide resin for coupling with the Cpg building block. 
They reproduce part of the helix-1 (IV.5-7) and of the helix-2 (IV.2-4 and IV.8) of the Id HLH motifs. 
 
Peptide 
no. 
Amino acid sequence Id fragment 
IV.2 KVEILQHVIDY Id1 91-101 
IV.3 KMEILQHVIDY Id2 61-71 
IV.4 QVEILQRVIDY Id3 66-76 
IV.5 NGCYSRLKELV Id1 70-80 
IV.6 NHCYSRLRELV Id3 45-55 
IV.7 NDCYSRLRRLV Id4 69-79 
IV.8 KVEIL Id1 91-95 
IV.9 VKEIQLVHIYD 
Id1 91-101 
scrambled 
 
 
Subsequently, the enantiopure Cpg units were coupled manually to the Id fragments to 
connect two equal sequences through their free N-termini (Figure 5). Although working in 
heterogeneous conditions, the Cpg dicarboxylate was not added in excess but rather 
stechiometrically, in order to minimize the formation of mono-substituted Cpg derivatives. 
Therefore, only 0.5 equiv. Cpg were dissolved in DMF together with DIC and HOBt as 
activating reagents, whereas no base was added to avoid epimerization. The coupling 
mixture was added to the previously swelled peptidyl-resin and shaken for 24 hours at 
room temperature. Successively, further DIC and HOBt were added and the reaction was 
left to run for another day. The reaction completion was controlled by cleaving a small 
amount of peptide from the resin and analyzing it by HPLC and MALDI-ToF-MS. 
Surprisingly, the two Cpg enantiomers were successfully coupled to the Id helix-2 related 
sequences, but not to the Id helix-1 related sequences. Indeed, IV.2, IV.3 and IV.9 were 
converted into the corresponding covalent dimers IV.10a/b, IV.11a/b and IV.12a/b 
(Figures 5 and 6), whereas IV.6 and IV.7 were only partially converted into the two 
possible monosubstituted Cpg derivatives.  
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Figure 5: Id peptide dimers containing Cpg in the SRS or RSR configuration. 
 
 
 
 
Figure 6: HPLC profile of the crude product of IV.10a. 
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Also the coupling of Cpg to peptide IV.8 was not successful: (SRS)-Cpg incompletely 
reacted with the pentapeptide, whereas its enantiomer could only be monosubstituted. This 
suggests that the stereochemistry of Cpg may also play a role in the coupling reaction. 
Nevertheless, the low yield of crosslinking for IV.8 was a bit surprising, but it is likely that 
the pseudo-dilution effect exerted by the solid support on the short-length peptide backbone 
disfavored intermolecular reactions [18]. 
 
Further, the Cpg building block has been used to anchor three peptide chains, as 
shown in Figure 7. In this case, the α-amino group of Cpg was Fmoc-protected, which 
allowed the assembly of the third chain after the coupling of Cpg on the peptidyl-resin. 
More precisely, the Fmoc-proteced Cpg was first coupled to peptide IV.2 under the same 
reaction conditions described above for the benzoyl-protected-Cpg. Acetylation with ten 
equiv. acetic anhydride followed to cap the eventually unreacted NH2 groups of the resin-
bound peptide chains. Due to the epimerization tendency of Cpg in the presence of bases, 
the commonly used mixture of piperidine in DMF was replaced with a mixture of DBU and 
HOBt in DMF to perform the Fmoc cleavage; indeed, although DBU is a stronger base than 
piperidine, it is less nucleophilic because of its sterically hindered nature. Moreover, highly 
diluted solutions of DBU and short reaction times (3-5 min) are already able to completely 
cleave the Fmoc group. The addition of HOBt is made to control the overall basicity of the 
mixture. The assembly of the Id1 fragment 70-80 was done manually using a double 
coupling procedure, with a high molar excess (8 equiv.) of the commercially available 
amino acids activated with DIC/HOBt (8 equiv. each). The Fmoc cleavage was performed 
with the DBU solution described above. Finally, the last amino acid was acetylated. With 
this protocol, peptides IV.13a/b were obtained with high homogeneity.  
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Figure 7: Synthesis of peptides IV.13a/b. For the preparation of Fmoc-protected Cpg see reference [15]. 
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IV.2.2  Conformational characterization of the Cpg-containing Id peptides by CD 
spectroscopy 
 
Peptides IV.10a/b and IV.11a/b differ only for the presence of a valine in place of a 
methionine, respectively, and this is not expected to strongly influence the conformation. 
Therefore, we chose to study the valine-containing peptides IV.10a/b because of the 
absence of oxidizing groups. The two diastereomers IV.10a/b were dissolved at the 
concentration of 90 µM in phosphate buffer (100 mM, pH 7.3) at room temperature, and 
were measured immediately after preparation as well as after one day. The CD spectra are 
reported in Figure 8. Compound IV.10a showed a broad negative band below 210 nm, 
followed by a negative maximum at 219 nm and a weak negative minimum at 225 nm 
(Figure 8A). In contrast, peptide IV.10b showed a negative band below 200 nm, followed 
by a weak positive maximum at 207 nm and a negative minimum at 222 nm. These 
dichroic data suggest that IV.10a was mostly disordered (local polyproline-II contributions 
are probably present, due to the presence of the negative maximum at 219 nm), whereas 
IV.10b was partially ordered, as suggested by the presence of the well-defined minimum at 
222 nm and the positive contribution at 207 nm. This is supported also from the CD spectra 
of the one-day old samples, as the one of IV.10a became clearly random-shaped, while the 
one of IV.10b underwent only a slight red shift (Figure 8B).  
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Figure 8: CD spectra of peptides IV.10a/b at the concentration of 90 μM in 100 mM phosphate buffer, pH 
7.3. (A) Freshly prepared and (B) one-day old samples.  
 
 
Further, comparison of the CD spectrum of the Id1 fragment alone with those of 
peptides IV.10a/b clearly showed that the Cpg unit with the configuration RSR induced a 
conformational transition from the disordered state of the single peptide chain to a partly 
ordered state of the corresponding covalent dimer (Figure 9A). Indeed, by subtracting the 
random component represented by the Id1 fragment alone from the spectrum of IV.10b, the 
resulting curve displayed a negative band at 223 nm and a positive one at 203 nm, which is 
indicative of the presence of a β-turn-like motif (Figure 9B). In contrast, the Cpg unit with 
the SRS configuration seemed to have almost no effect on the random conformation of the 
Id1 fragment, as suggested by the CD spectrum difference which is not significant over the 
region 205-260 nm 
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Figure 9: A) Comparison of the CD spectrum of Ac-(91-101)-Id1 with those of the peptides IV.10a/b. B) CD 
spectrum differences showing the CD intensity contribution of the Cpg units to the CD spectra of IV.10a/b.  
 
 
Taking these observations together, it can be suggested that (RSR)-Cpg favored a β-
turn or a β-bend conformation in IV.10b, which should allow the two flanking peptide 
chains to point into the same direction, whereas its enantiomer was probably unable to 
induce a preferred conformation.  
 
 
IV.2.3  Investigation of the interaction of the Cpg-containing Id peptides with the 
native Id1 HLH motif by CD spectroscopy 
 
As peptides IV.10a/b represent a dimeric form of part of the Id1 helix-2, we 
investigated their potential to interact with the native HLH motif of Id1 by CD 
spectroscopy. Each Cpg-containing peptide was mixed with the HLH motif in the ratio 3:1, 
in order to favor partner- rather than self-interactions of the latter. The peptide mixtures 
were measured immediately after preparation as well as the day after (Figure 10). Very 
weak peptide interactions were detected in the fresh mixture containing IV.10a, as 
indicated by the fact that the CD spectrum of the mixture was almost superimposable to the 
arithmetic sum of the CD spectra of the two separated peptides (Figure 10A). However, the 
one-day old mixture showed a well-defined helix-like CD curve that was characterized by a 
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significantly more intense maximum at 197 nm than the one obtained by the sum of the CD 
spectra of the two separated peptides (Figure 10C). This suggests that an interaction of 
IV.10a with the Id1 HLH motif occurred, which resulted in increased helicity. In the case 
of peptide IV.10b, an interaction with the Id1 HLH motif could be detected already in the 
fresh mixture. Indeed, the CD spectrum of the mixture was completely different from the 
one corresponding to the arithmetical sum of the two separated peptides (Figure10B), 
displaying a negative band at 220 nm. Also the CD spectrum of the one-day old mixture 
showed the same shape but the minimum at 220 nm became more intense and a weak 
positive band at 201 nm appeared (Figure 10D). Thus, the peptide IV.10b was strongly 
interacting with the Id1 HLH motif, leading to a conformational change characterized by 
the formation of a β-sheet structure which was stabilized with the time. The presence of an 
isodichroic point at 200 nm suggests that a transition from an α-helix conformation to a β-
sheet one took place in the mixture.  
Taken together, these data suggest that both the Cpg-containing peptides were 
interacting with the Id1 HLH motif, but in a different manner: the one containing RSR-Cpg 
induced a rapid β-sheet conformation, whereas its diastereomer weakly stabilized the α-
helix conformation.  
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Figure 10: CD spectra of the peptides IV.10a and Id1 HLH motif, and of their 3:1 mixture. The three samples 
were measured immediately after preparation (A) or the day after (C). CD spectra of the peptides IV.10b and 
Id1 HLH motif, and of their 3:1 mixture. The three samples were measured immediately after preparation (B) 
or the day after (D). All samples were prepared in 100 mM phosphate buffer, pH 7.3. The dotted CD curves 
correspond to the arithmetic sum of the CD spectra of the two components of the mixture. 
 
 
IV.2.4  Preliminary assays of the Cpg-containing Id peptides on a cellular model for 
atherosclerosis 
 
There is clear evidence that the Id proteins regulate vascular smooth muscle cell 
(VSMC) growth and differentiation, and, consequently, their dysregulation contributes to 
vasculoproliferative disorders.[19]. Several data suggest that the Id proteins are mediators 
of various mitogenic factors acting generally through receptor tyrosine kinases: for 
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example, receptor tyrosine kinase stimulation by the platelet derived growth factor (PDGF) 
or serum increases both Id protein expression and VSMC growth. Another early response 
gene is c-Myc that activates Id2 gene transcription and is upregulated after vascular injury. 
In addition to their growth promoting properties, the Id proteins act as negative regulators 
of cellular differentiation. Modulation of the VSMC phenotype consisting in an alteration 
of their differentiated state is a hallmark of vascular lesion formation. As the primary 
function of VSMC is to contract, the expression of smooth muscle (SM) specific contractile 
proteins, like SM α-actin, is commonly used as an indicator of VSMC differentiation. In 
vivo expression of VSMC differentiation markers, including α-actin, decreases after 
vascular injury at time points coincident with the upregulation of Id2 and Id3. Therefore, 
the Id proteins are likely to be important mediators of the dedifferentiated state of VSMC 
during lesion formation.  
Based on the CD spectroscopy data reported above, the Cpg-containing Id peptides 
IV.10a/b are apparently able to interact with the native Id HLH motif. Therefore, we were 
interested in the evaluation of these compounds in a cellular system. The synthetic 
phenotype of the human VSMC is characterized by decreased α-actin expression and 
increased proliferation and migration, thus offering a suitable cellular system to study 
atherosclerosis. To investigate the effect of the compounds on cell proliferation, VSMC 
cultures synchronized at the G0 phase of the cell cycle were stimulated for three days with 
10% FCS medium in the presence and in the absence of growing concentrations of 
peptides. As shown in Figure 11, compounds IV.10a/b showed a similar antiproliferative 
effect in the low micromolar range by reducing the number of cells of about 40%. As 
expected, also the mixture of the two diastereomers represented by peptide IV.1 induced a 
similar decrease in cell proliferation. In contrast, the peptide corresponding to the single 
helix-2 of Id2 had no antiproliferative effect. These preliminary results suggest that the 
dimeric form of the Id helix-2 fragment connected by the (SRS)- or (RSR)-Cpg units were 
able to negatively affect cell proliferation, whereas the monomeric form of the Id helix-2 
was not. Although the potency and efficacy of the tested Cpg-containing Id peptides is not 
satisfactory, nevertheless they may provide a starting point for the development of peptide-
based compounds with improved pharmacological properties. One of the problems that 
must be overcome is the difficult cell uptake: one possible solution might be the 
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substitution of the benzoyl group of IV.10a/b with an arginine-rich peptide chain, which is 
known to favor cell membrane penetration and act as a molecular transporter for drug 
delivery [20]. 
 
 
 
Figure 11: Effect of the Cpg-containing Id peptides IV.10a/b and of their diastereomer mixture (IV.1) on the 
proliferation of the synthetic phenotype of VSMC, and comparison with the effect of the Id2 helix-2. 
 
As mentioned above, α-actin is a marker for differentiation of SM cells. The ability 
of the Cpg-containing peptides to induce differentiation of the synthetic phenotype of 
VSMC was evaluated by detecting the α-actin expression in the presence of growing 
peptide concentration. The effect of IV.1 and IV.10a on the expression levels of α-actin is 
shown in Figure 12: both peptides positively affected the expression of the protein, whereas 
the peptide IV.11a containing the scrambled peptide sequence had not effect. This suggests 
that compounds IV.1 and IV10a not only were able to reduce cell proliferation, but also to 
promote cell differentiation. Moreover, this effect was specific for the compounds 
containing the correct Id helix-2 sequence, as the compound displaying the corresponding 
scrambled sequence was inactive.  
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Figure 12: Effect of the Cpg-containing Id peptides IV.1 and IV.10a on the expression levels of α-actin in 
the synthetic phenotype of VSMC, and comparison with the effect of IV.11a containing the scrambled 
sequence of the Id1 fragment 91-101. 
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Finally, the effect of IV.1 on cell migration was tested by using a modified Boyden 
chamber assay. In the lower chamber, the medium contained 20 ng/ml PDGF as the 
chemotactic agent and the peptide (two different concentrations were tested: 1 µM and 10 
µM). Migration of the cells from the upper chamber to the lower chamber was assessed 
after eight hours incubation. A moderate but still significant reduction of cell migration was 
observed, as shown in Figure 13. 
 
 
 
Figure 13: Effect of the Cpg-containing Id peptide IV.1 on cell migration of the synthetic phenotype of 
VSMC (HPF, high power field).  
 
 
All together, these preliminary data suggest that the Cpg-containing Id peptides 
investigated in this work might influence the inhibitory activity of the Id proteins, as they 
were able to inhibit VSMC proliferation and migration, while inducing differentiation. 
However, their potency is only in the micromolar range and needs to be improved, together 
with their cellular uptake and, of course, proteolytic stability.  
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IV.3  Small peptides containing the building block 3,4-(aminomethano)proline 
(Amp)  
 
In the last decade, many efforts have been made to design and develop new 
oligopeptides, so called foldamers, which exist in a well-defined conformation in solution. 
These molecules aim to mimic or even to expand the functions of nature. The pioneering 
work of Gellman [21-23] and Seebach [24-26] on β-peptides designing oligomers of cyclic 
and acyclic β-amino acids has shown the power of these chemical tools in a number of 
biological applications. β-Peptides can in fact adopt ordered structures in solution, like 
helices defined by 8- up to 14-membered hydrogen-bonded rings [26]. Besides β-peptides, 
also α/β-peptides [12, 27], γ-peptides [28] and δ-peptides [29] have been described as 
promising biologically active compounds characterized by ordered solution structures. 
Therefore, the synthesis of new unnatural, structurally constrained amino acids and their 
application in the development of new oligomers with interesting architectures are a 
worthwhile research field in chemistry.  
Recently, the synthesis of the unnatural amino acid 3,4-(aminomethano)proline 
(Amp) has been reported by de Meijere and co-workers [30]. Amp not only represents a 
derivative of proline, but it can be also seen as a conformationally constrained analogue of 
lysine, ornithine and, upon guanidinylation of the γ-amino group, of arginine. Moreover, it 
can be used both as cyclic α- and bicyclic γ-amino acid, as well as for the synthesis of 
branched peptides (Figure 14). 
 
 
 
Figure 14: The Amp building block contains a secondary and a primary amine that can be used for the 
synthesis of α- and γ-peptides, respectively, or can be connected to the C-end of peptides to obtain branched 
peptides. 
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To investigate the potential of Amp as building block for peptide and foldamer synthesis, 
de Meijere and co-workers developed a synthetic route to obtain both the Boc/Fmoc-
protected Amp enantiomers (Scheme 4) [31]. 
 
 
Scheme 4:  Synthesis of (2R, 1’S, 3S, 4S)-Amp from the enantiopure 3,4-(aminomethano)-prolinol (for its 
synthesis see reference [31]). The enantiomer (2S, 1’R, 3R, 4R)-Amp comes from the corresponding 
enantiopure 3,4-(aminomethano)-prolinol with the same procedure (for details see reference [32]). 
 
 
 
 
IV.3.1  Incorporation of Amp in small α/γ  peptides [31] 
 
An extensive research of the β-peptide class of foldamers has provided several new 
secondary structures. Besides β-peptides, also γ-peptides can fold in regular structures both 
in solution and on the solid state. Theoretical predictions by Hofmann and co-workers 
about γ-peptides revealed that structures with 14- and 9-membered helices are the most 
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stable in solution [33]. Hanessian et al. showed that γ-amino acids can favor a 14-helix [34] 
or reverse turns, whose screw sense depends on the stereochemistry of the γ-residue [35]. 
These findings are supported also by the studies of Seebach and co-workers, who observed 
the presence of 9-membered hydrogen-bonded rings in γ-peptides [36, 37]. Other examples 
by Ferrera-Sinfreu et al. [28] describe 9-membered sheets in γ-peptides containing cyclic γ-
amino acids [28], while the acyclic γ-amino acids of Balaram and co-workers [38] made the 
peptides adopt 9-membered helices and ribbons. Kunwar and co-workers synthesized 
mixed γ-peptides [39] which can fold into a left-handed 9-helix in chloroform. 
It has been shown that the structural features of all β- or mixed α/β-peptides are 
compatible with the world of the natural α-peptides, and that these unnatural foldamers can 
be potent tools to target protein-protein interactions [40, 41]. As the mode of action of the 
Id proteins is dictated by intermolecular contacts between helices, developing and using 
foldamers might be a powerful approach to target the Id proteins. Due to the ability of 
peptides containing γ-amino acids to adopt helical structures, we decided to undergo a 
synthetic and structural study of alternating α/γ-peptides containing the Amp unit [31]. 
Both enantiomers of Nγ-Fmoc/Nα-Boc-protected Amp shown in Figure 15 were used for 
solid phase synthesis of alternating α/γ-oligomers consisting of the dipeptide repeat α-Ala-
γ-Amp (Figure 15). The chain assembly was performed manually on Rink amide resin with 
an initial loading of 0.7 mmol/g. The dipeptide Gly-Tyr was chosen as general C-terminal 
motif for two reasons: (i) Gly can function as short spacer between the C-end and the core 
sequence, whereas (ii) Tyr provides the oligomer with an internal chromophore, which is 
advantageous for the determination of the concentration by UV spectroscopy. As the 
oligomers presented here were cleaved-off from the resin before removing the last Fmoc 
group, their concentration was determined from the UV absorption of the fluorene moiety 
at 301 nm.  
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Figure 15: Orthogonally protected Amp derivatives (top) used for the solid phase synthesis of the 
oligomers IV.14a/b and IV.15a/b (bottom). 
 
 
A single-coupling procedure was applied for the building block as well as for the natural 
amino acids in the presence of DIC and HOBt; however, whereas the acylation steps 
involving Amp were carried out using a moderate molar excess (2.5 equiv.) and a longer 
reaction time (16 h), those involving the commercially available amino acids were carried 
out using higher molar excess (4 equiv.) and a shorter reaction time (4 h). To control the 
quality of the growing peptide chain, a small-scale TFA cleavage was performed after each 
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γ-Amp coupling, and the cleaved-off product was characterized by analytical HPLC and 
mass spectrometry. The Fmoc cleavage steps were accomplished by using a mixture of 
DBU and HOBt in DMF (3-5 min). With this synthetic procedure, hexamers IV.14a and 
IV.15a and octamers IV.14b and IV.15b could be obtained with high homogeneity already 
after TFA cleavage from the resin and precipitation from ice-cold diethyl ether (Figure 16). 
 
 
 
 
Figure 16: HPLC profiles of peptides IV.14a (left) and IV.14b (right)  
 
 
IV.3.2  Structural investigation of the Amp-containing  α/γ peptides  
 
The synthesized α/γ-peptides were studied by CD and NMR spectroscopy. The CD 
spectra were analyzed in the far-UV region of the amide bond transitions (195-260 nm). 
Both the hexamer IV.14a and octamer IV.14b containing the γ-Amp unit with the (2S, 1’R, 
3R, 4R)-configuration were characterized in water by a positive signal in the range 200-240 
nm, with a maximum at 208 nm for the hexamer or at 212 nm for the octamer, followed by 
a shoulder at 225 nm. The CD signal became negative below 198 nm (Figure 17A-B). The 
same CD shape was found in methanol, in which, however, the positive maximum for both 
oligomers was slightly blue-shifted to 205 nm; moreover, in the organic solvent peptide 
IV.14b showed a more intense spectrum with respect to peptide IV.14a, indicating a 
superior conformational stability for the longer peptide chain. Interestingly, these CD 
spectra are similar in the shape to those recently reported by Kunwar and co-workers [42] 
for solutions in methanol of α/γ-peptides containing acyclic γ-amino acids: NMR studies of 
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the latter had shown the presence of a helical conformation with high and moderate 
stability in chloroform and methanol, respectively [42] . 
In contrast to IV.14a and IV.14b, oligomers IV.15a and IV.15b containing the γ-
Amp unit with the (2R, 1’S, 3S, 4S)-configuration presented completely different Cotton 
effects, as they were characterized by a negative CD signal in the range 195-225 nm. In 
water, IV.15a and IV.15b displayed an intense minimum near 207 nm, which was slightly 
red-shifted in methanol (to 211 nm for IV.15a and to 209 nm for IV.15b). Additionally, a 
weak positive band was detected near 230 nm for the two peptides in both solvents, with a 
crossover close to 225 nm (Figure 17C-D). 
The dichroic properties of the four oligomers suggest that the enantiomers of γ-Amp 
induced two different ordered conformations that were described by opposite Cotton effects 
in the region 200-225 nm, positive in the case of the (2S, 1’R, 3R, 4R)-configuration and 
negative in the case of the (2R, 1’S, 3S, 4S)-configuration. Moreover, the induced 
conformations appeared to be not significantly affected by the change of the solvent from 
water to methanol. 
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Figure 17: CD spectra of IV.14a/b at the concentration of 100 μM in water (A) and in methanol (B). CD 
spectra of IV.15a/b at the concentration of 50 μM in water (C) and in methanol (D).  
 
 
Further, the four α/γ-peptides were dissolved in methanol-d3 and studied by NMR 
spectroscopy. 1D experiments were first acquired at four different temperatures (278, 283, 
293 and 303 K), and the one that gave the better resolved spectrum was chosen to record 
the 2D experiments. The complete 1H NMR resonance and sequence assignments were 
done by using the COSY, TOCSY and NOESY spectra. Sequential and interresidue NOE 
crosspeak intensities were classified as strong (2-2.5 Å), medium (2-4 Å) and weak (2-5 Å) 
based on the number of contours in the contour plot of the NOESY spectrum. The values of 
the 3J coupling constants (3Jα(γ)N) between the α-NH and the α-CH, or the γ-NH and the γ-
CH in the case of the Amp unit, were estimated by the using the amide region in the 1D-
NMR spectrum.  
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The NOE pattern, the 3Jα(γ)N values and the temperature coefficients for the α- and γ-NH 
obtained for the hexamer IV.14a containing Amp in the (2S, 1’R, 3R, 4R)-configuration are 
reported in Table 2 and Figure 18. With the exception of the C-terminal Tyr residue, the 
other α-residues all presented a vicinal coupling constant value of 6, whereas the two γ-
Amp units showed the very low value of 2.4. The temperature coefficients were in the 
range of 3.7-7.6 ppb/K, with the Ala-3 and Gly-5 amide protons showing the lower values 
(4.2 and 3.7, respectively). The strong dαN NOE and the weak dNN and dβN NOEs between 
Ala-1 and γ-Amp-2 might indicate the presence of a turn. Also the medium dβN NOEs 
between γ-Amp-2 and Ala-3, Ala-3 and γ-Amp-4, and γ-Amp-4 and Gly-5 might reflect the 
presence of turn elements. Unfortunately, the number of NMR constraints observed under 
these conditions was not sufficient to carry out a structure calculation.  
 
Table 2: NOE pattern, 3Jα(γ)N values (all at 278 K) and temperature coefficients for the α- and γ-
NH observed for IV.14a in methanol. Bar thickness reflects the NOE intensities as strong, 
medium and weak. 
Residue Ala-1 γ-Amp-2 Ala-3 γ-Amp-4 Gly-5 Tyr-6 
3Jα(γ)N 6 2.4 6 2.4 6 7.8 
-Δδ/ΔT 
(ppb/K) 
7.6 6.1 4.2 5.4 3.7 7.0 
dNN(i; i+1)       
dαN(i; i+1)       
dβN(i; i+1)       
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Figure 18: Summary of the interresidue NOE constraints observed for the peptide IV.14a in methanol al 278 
K (red arrows: dαN NOEs; green arrows: dβN NOEs; blue arrows: dNN NOEs). 
 
 
The NOE pattern, the 3Jα(γ)N values and the temperature coefficients for the α- and γ-NH 
obtained for the octamer IV.14b containing Amp in the (2S, 1’R, 3R, 4R)-configuration are 
reported in Table 3. As observed for peptide IV.14a, the alanine residues presented the 
same value of 6.3 for the vicinal coupling constant, which is only slightly higher than the 
3JαN value of 6 found for the alanine residues in the hexamer. In contrast, the glycine 
coupling constant decreased from 6 to 5.3, and that of the three γ-Amp units could not be 
estimated from the 1D NMR spectrum. However, it should be noted that the NMR 
experiments of peptide IV.14b were recorded at 283 K and not at 278 K, as it was done for 
the hexamer IV.14a. The different temperature might explain the change in the values of 
the coupling constants between the hexamer and the octamer. The temperature coefficients 
were in the range of 3.7-8.0 ppb/K, with the Ala-3 and Gly-7 amide protons showing the 
lower values (4.0 and 3.7, respectively), while the N-terminal Ala-1 and the C-terminal 
Tyr-8 showing the higher values (8.0 and 7.0 ppb/K, respectively). Strong and medium dαN 
(i; i+1) NOEs were found in the region from Ala-1 to Gly-7, and weak dNN (i; i+1) NOEs 
were observed between Ala-3 and γ-Amp-4 and in the region from Ala-5 to Tyr-8. Medium 
dβN NOEs were found between Ala-5 and γ-Amp-6, and between Gly-7 and Tyr-8, whereas 
a weak one was found between Ala-1 and γ-Amp-2. Besides these sequential NOEs, also 
medium-range NOEs were detected: in particular, two medium dβN (i; i+3) NOEs were 
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detected between γ-Amp-2 and Ala-5, and between γ-Amp-4 and Gly-7, together with two 
weak dNN (i; i+3) NOEs between γ-Amp-2 and Ala-5, and between Ala-5 and Tyr-8 
(Figure 19). This (i; i+3) periodicity might indicate the presence of an ordered structure, 
thus supporting the CD data. 
 
 
Table 3: NOE pattern, 3Jα(γ)N values (all at 283 K) and temperature coefficients for the α- and γ-NH 
observed for IV.14b in methanol. Bar thickness reflects the NOE intensities as strong, medium and weak. 
Residue Ala-1 γ-Amp-2 Ala-3 γ-Amp-4 Ala-5 γ-Amp-6 Gly-7 Tyr-8 
3Jα(γ)N 6.30 n.d 6.30 n.d. 6.30 n.d. 5.30 7.60 
-Δδ/ΔT 
(ppb/K) 
8.0 6.5 4.8 5.7 4.0 5.7 3.7 7.0 
dNN(i; i+1)         
dNN(i; i+3)         
dαN(i; i+1)         
dβN(i; i+1)         
dNγ(i; i+1)         
dβN(i; i+3)         
 
 
 
 
Figure 19: Summary of the medium-range interresidue NOE constraints observed for the peptide IV.14b in 
methanol al 283 K (green arrows: dβN (i; i+3) NOEs; blue arrows: dNN (i; i+3) NOEs). 
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Theoretical studies performed by Hofmann and co-workers have shown that structural 
similarities exist between acyclic α/γ-peptides and β-peptides [43]; moreover, these studies 
have also indicated that the most stable helix type for α/γ-alternating peptides in a polar 
medium is the helix-12, stabilized by hydrogen bonds between the carbonyl group of 
residue i and the amide proton of residue i+3, whereas the mixed 12/10-helix is less 
favored in a polar solvent [43]. In order to investigate which kind of energetically favored 
conformations could be assumed by the α/γ-peptide IV.14b, a systematic search was 
performed on a simplified analogue of this molecule, in which the N-terminal Fmoc-alanine 
was substituted by an acetyl group, whereas the C-terminal glycine and tyrosine were 
omitted (Figure 20). For practical reasons, however, the same residue numbers have been 
maintained as in peptide IV.14b. The conformational search was performed assuming that 
(i) bond lengths and bond angles are fixed, (ii) the amide bonds are in the trans 
configuration and can not rotate, (iii) the distance constraints corresponding to the two 
medium dβN (i; i+3) NOEs (2-4 Å) must be satisfied. All rotable bonds in the molecule 
(Figure 20), with the exception of φ 1, were systematically rotated through 360° using a 
fixed increment of 30° (for Ψ 2,  φ 5,  Ψ 6, φ  9 and Ψ 10) and of 60° (for φ 3,  Ψ 4,  φ  7, 
and Ψ 8). 225 possible conformations were found and each of them was minimized by 
using the dielectric constant of methanol (30), in order to reproduce the same polar 
environment of the NMR experiments.  
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Figure 20: Structure of the IV.14b analogue used for the systematic search. Red arrows indicate all the 
backbone torsion angles in the structure; φ1 was not considered in the study. 
 
 
Among all the minimized conformations, special attention was given to the conformer 
families presenting a periodicity in torsion angle values, which could indicate a helical fold. 
In particular, there was a group of structures stabilized by the presence of two hydrogen 
bonds involving 9 or 7 atoms, with a periodicity of i, i+2. In these conformers the values of 
torsion angles Ψ 2 were similar to those of Ψ 6 and Ψ 10, and at the same time φ 3 was 
similar to φ  7, Ψ  4 to Ψ 8, and φ  5 to φ  9 (structures A and B in Table 4).  
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One example is shown in Figure 21A, where the folded molecule presents 9-membered-
hydrogen-bonded rings, in which the first bond takes place between the CO of Ala-3 and 
the NH of Ala-5, and the second one between the CO of Ala-5 and the NH at the C-
terminus that corresponds to the amide of Gly-7 in IV.14b. Furthermore, the C-terminal 
NH group can interact also with the CO of γ-Amp-2, as the distance between the proton and 
oxygen atoms is of 2.13 Å. 
The conformation represented in Figure 21B is characterized by 7-membered-hydrogen-
bonded rings, with a hydrogen bond formed between the CO of γ-Amp-2 and the NH of γ-
Amp-4, followed by a second one between the CO of γ-Amp-4 and the NH of γ-Amp-6. 
The conformations with the lowest values of minimum energy where characterized by a 
periodicity in torsion angle, in which Ψ2 ~ Ψ 6 and φ  3 ~ φ  7 (structures C and D in Table 
4). They can also fold into helical structures, but no hydrogen bonds can be detected. 
Among these conformers, two of them resulted particularly interesting and are reported in 
panels C and D of Figure 21. In the first one (Figure 21C) the distance between the amide 
proton of Ala-5 and the oxygen of the CO group of Ala-3 is of ~ 3 Å, as well as the 
distance between the NH of Ala-3 and the CO that would correspond to the one of Ala-1 in 
IV.14b. In this case, it can be said that two long hydrogen bonds could be formed with a 
periodicity of i, i+2. The structure reported in Figure 21D is also characterized by two long 
hydrogen bonds, involving the CO of Ala-3 that can interact either with the NH of γ-Amp-6 
or with the one of Ala-5. Interestingly, when these two conformers are minimized using a 
dielectric constant of 1 to simulate an apolar environment, the distances between the cited 
Table 4: Backbone torsion angles a of the conformations A-D presented in Figure 21. 
 γ-Amp-2 Ala-3 γ-Amp-4 Ala-5 γ-Amp-6 
 φ1 Ψ2 φ3 Ψ4 φ5 Ψ6 φ7 Ψ8 φ9 Ψ10 
A 61 179 -83 160 56 176 -76 148 55 -175 
B 60 -173 -72 83 74 -170 -69 81 98 -169 
C 59 -175 -78 153 54 177 -60 -47 -149 -55 
D 60 174 -78 161 53 176 -64 -40 -117 -171 
a Torsion angles are defined for Ala as follows : φ→ C-Nα-Cα-C; Ψ→ N-Cα-C-Nγ 
Torsion angles are defines for Amp as follows: φ→ C-Nγ-Cγ-Cβ; Ψ→ NR-Cα-C-Nα 
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atoms decrease, reaching values of ~ 1.8 Å. This means that in these conditions hydrogen 
bonds could be formed, and that the conformations are more stable in an apolar solvent 
than in methanol.  
These data show that peptide IV.14b can adopt an ordered helical conformation. All 
possible conformations are in agreement with the NMR data and with the values of 
temperature coefficients of amide protons of the core structure of peptide IV.14b. As a 
matter of fact, these values indicate that these amide protons could be either involved in 
hydrogen bonds or solvent shielded, and both cases are possible in the conformations found 
by the systematic search. Moreover, the observation that some of the structures were 
stabilized in apolar solvents is in agreement with the data reported in literature for acyclic 
α/γ-peptides [42, 43], with the difference that the periodicity of hydrogen bond pattern we 
found is i, i+2 and not i, i+3 or the mixed i, i+1/i, i+3. Anyway, this is not surprising, as we 
are dealing with a by-cyclic γ-amino acid that is, of course, more constrained than an 
acyclic one. 
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Figure 21: Examples of possible conformations adopted by the simplified analogue of peptide IV.14b in a 
polar environment, as found by the systematic search. Dotted black lines represent hydrogen bonds; in the 
case of long hydrogen bonds, the distances are also shown.  
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Summarizing, the hexamer IV.14a and the octamer IV.14b have displayed CD 
spectra similar to those reported for acyclic α/γ-peptides with moderate to high helix 
propensity [42]. Moreover, the NMR data observed for the octamer, together with the 
computational analysis, support the presence of an ordered structure with a well-defined 
periodicity that may be further stabilized by increasing the apolar character of the solvent.  
 
The NMR data collected for peptide IV.15a, the hexamer containing the γ-Amp unit 
in the (2R, 1’S, 3S, 4S)-configuration, are reported in Table 5 and Figure 22. The 3Jα(γ)N 
values from the 1D NMR spectrum at 283 K could be detected only for Ala-1 (6.5), Ala-3 
(6.1) and Tyr-7 (7.7). The temperature coefficients were in the range of 4.0-7.5 ppb/K, with 
the Ala-3 and Gly-5 amide protons showing the lower values (4.2 and 4.0, respectively). 
The similar pattern of sequential NOEs in the region from γ-Amp-2 to γ-Amp-4 (strong to 
medium dαN NOEs, medium to weak dβN NOEs and weak dNN NOEs) suggest the formation 
of a secondary structure, probably two sequential bends. Also the weak dNN NOE and the 
medium dβN NOE between γ-Amp-4 and Gly-5 might reflect the presence of a turn.  
 
 
Table 5: NOE pattern, 3Jα(γ)N values (all at 283 K) and temperature coefficients for the α- and γ-
NH observed for IV.15a in methanol. Bar thickness reflects the NOE intensities as strong, 
medium and weak. 
Residue Ala-1 γ-Amp-2 Ala-3 γ-Amp-4 Gly-5 Tyr-6 
3Jα(γ)N 6.5 n.d. 6.1 n.d. n.d. 7.7 
-Δδ/ΔT 
(ppb/K) 
7.5 6.3 4.2 5.1 4.0 6.9 
dNN(i; i+1)       
dαN(i; i+1)       
dβN(i; i+1)       
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Figure 22: Summary of the interresidue NOE constraints observed for the peptide IV.15a in methanol at 283 
K (red arrows: dαN NOEs; green arrows: dβN NOEs; blue arrows: dNN NOEs). 
 
 
The presence of a structured peptide is supported from the splitting (Δδ of 0.3 ppm) of the 
diastereotopic α-protons of Gly-5 (Figure 23). This splitting has been usually observed in 
peptides, in which the glycine residue was locked in a turn edge, and the magnitude of the 
splitting has been also directly correlated with the turn stability in a number of structural 
studies [44].  
 
 
Figure 23: Fingerprint region of the COSY spectrum of peptide IV.15a (283 K) showing the diastereotopic 
α-protons of Gly-5. 
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Moreover, Gly-5, together with Ala-3, possesses a low temperature coefficient (4.0 ppb/K), 
suggesting that the amide proton might be involved in a hydrogen bond that would stabilize 
the turn conformation. Unfortunately, the number of NMR constraints observed under these 
conditions was not sufficient to carry out a structure calculation.  
 
The NMR spectra of the octamer IV.15b containing the γ-Amp units with the same 
configuration like in the hexamer IV.15a were characterized by strong overlap under the 
conditions used for the other three peptides described above. Consequently, no further 
conformational data could be obtained for IV.15b. 
 
In conclusion, the CD and NMR investigations presented here suggest that alternating 
α/γ-peptides containing the γ-Amp building block can adopt ordered secondary structures 
which depend on the configuration of the γ-amino acid. In fact, the γ-Amp in the (2S, 1’R, 
3R, 4R)-configuration might favor a helical backbone, whereas the γ-Amp in the (2R, 1’S, 
3S, 4S)-configuration might induce a bend-like structure. 
 
 
IV.3.3  Incorporation of Amp in small α-peptides  
 
Besides its application as a γ-amino acid, we also tested the Amp unit as proline 
analogue by using the enantiomers of Nγ-Boc/Nα-Fmoc-protected Amp for solid phase 
peptide synthesis (Figure 15). Depending on their stereochemistry, the Amp amino acids 
can be seen as analogues of LPro in the case of the (2S, 1’R, 3R, 4R)-configuration, and of 
DPro in the case of the (2R, 1’S, 3S, 4S)-configuration. 
Proline is the amino acid with the highest propensity to occur into turn structures in 
proteins [45], due to the constraints of the pyrrolidine ring. Proline-containing turns 
stabilized by a 4→1 hydrogen bond have been suggested to be natural templates for 
nucleating both β-hairpins and helical structures [46]. There different types of β-turns 
which vary in the dihedral angles of the residues i+1 and i+2: the most common types of β-
turns are the type I and the type II, together with their mirror images I' and II'. The segment 
DPro-LPro is known to stabilize the type II' turn and can favor helix propagation, but it can 
 Toward peptidomimetics as modulators of Id-protein-protein interaction 107
also be used as an effective hairpin inducer in both cyclic and acyclic peptides [47]. Also 
DPro-Xxx has demonstrated to be an effective hairpin nucleator [48]. Instead, a consecution 
of II'-I turns can nucleate a right-handed helix, whereas the enantomeric structure (II-I') can 
facilitate the formation of a left-handed helix [46].  
The Nγ-Boc/Nα-Fmoc-protected Amp with the (2S, 1’R, 3R, 4R)-configuration was used for 
preliminary studies on small peptides consisting of the repeats Gly-α-Amp. The chain 
assembly was performed manually on Rink amide resin with an initial loading of 0.7 
mmol/g. The dipeptide Gly-Tyr was chosen as general C-terminal motif for the reasons 
discussed above for the α/γ-peptides. A single-coupling procedure was applied for the 
building block as well as for the natural amino acids in the presence of HBTU, HOBt and 
DIPEA; however, whereas the acylation steps involving α-Amp were carried out using a 
moderate molar excess (2.2 equiv.) and a longer reaction time (90 min), those involving the 
commercially available amino acids were carried out using a higher molar excess (4 
equiv.). The Fmoc cleavage steps were accomplished with a mixture of DBU and HOBt in 
DMF, by treating the peptidyl-resin for short times (3-5 min). To monitor the peptide chain 
growth, a small amount of peptidyl-resin was subjected to TFA cleavage after the first α-
Amp coupling, and the cleaved-off product was characterized by mass spectrometry, which 
gave the expected mass for the tripeptide. Therefore, after glycine coupling, it was decided 
to elongate the peptide chain with the second Gly-α-Amp repeat without further monitoring 
of the acylation reactions. Unfortunately, when a small-scale TFA cleavage was performed 
at this point, only the product corresponding to the peptide lacking the second α-Amp unit 
was detected by mass spectrometry. Thus, the pentapeptide Fmoc-Gly-Gly-α-Amp-Gly-
Tyr-amide (IV.16) was totally cleaved from the resin and further characterized. Its CD 
spectrum in methanol was characterized by a negative band at 208 nm, followed by an 
almost equally intense positive signal at 229 nm, with a crossover at 219 nm (Figure 24A). 
This shape might reflect an exciton splitting [49], which takes place when two 
chromophores are close enough in the space to allow their dipoles interact. In the case of 
peptide IV.16, an exaction splitting can occur if the C-terminal tyrosine side chain and the 
N-terminal Fmoc group are spatially close, which would imply the presence of a central 
turn in the peptide.   
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Figure 24: (A) Structure of peptide IV.16 and (B) its CD spectrum (100 µM m in methanol). 
 
In order to distinguish the contribution of α-Amp from that of additional favorable 
interactions between aromatic residues to induce and stabilize turns and hairpin-like 
structures, two pentapeptides differing only in the N-terminal residue were synthesized: 
peptides IV.17a contained Ala-1, whereas peptide IV.17b contained Phe-1 (Figure 25). The 
chain assembly was performed manually on Rink amide resin using a single-coupling 
procedure for the building block (2.5 equiv.) as well as for the natural amino acids (4 
equiv.) in the presence of DIC and HOBt. The Fmoc cleavage steps were accomplished 
with a mixture of DBU and HOBt in DMF, by treating the peptidyl-resin for short times (3-
5 min). Acetylation of the N-terminal residue was performed with acetic anhydride (10 
equiv.) in DMF for 30 min. After final TFA cleavage, both crude peptides showed a purity 
near 90% and, thus, were not further purified. For a comparative study, the corresponding 
pentapeptides IV.18a/b containing LPro instead of α-Amp were synthesized, as well as the 
pentapeptides IV.19a/b containing the α-Amp with the (2R, 1’S, 3S, 4S)-configuration 
(Figure 23). 
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Figure 25: Structures of peptides IV.17a/b, IV.18a/b and IV.19a/b.  
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IV.3.4  Structural investigation of peptides containing α-Amp 
 
The peptides were characterized by CD spectroscopy in methanol. The proline-
containing sequences IV.18a/b were both characterized by negative ellipticity over the 
amide region, indicating that these two compounds adopt a disordered conformation 
(Figure.26A). In contrast, peptides IV.17a/b containing the α-Amp with the (2S, 1’R, 3R, 
4R)-configuration showed a different CD behavior that was also depending on the N-
terminal residue. Indeed, with Ala-1 (IV.17a) the CD spectrum was positive between 215 
and 240 nm, with a weak maximum at 228 nm, and negative below 215 nm, whereas with 
Phe-1 (IV.17b) the CD curve was characterized by two bands of opposite intensity at 222 
nm (positive) and 203 nm (negative), with a crossover at 213 nm (Figure 26B). The 
spectrum of IV.17a is similar to the one obtained for polyproline II peptides, whose 
hallmark is a positive CD signal between 220 and 230 nm and a strong negative band near 
200 nm. Instead, in the spectrum of peptide IV.17b the contribution of an exciton splitting 
could be detected, thus suggesting an interaction between the two aromatic residues Phe-1 
and Tyr-5. These observations would support a stabilization of a turn element in the 
peptides IV.17b and IV.16 by π−π contacts between aromatic side chains.  
A different CD shape has been found by the peptides IV.19a/b containing the α-Amp 
with the (2R, 1’S, 3S, 4S)-configuration (Figure 26C), which was characterized by a 
negative band below 195 nm, a maximum at 201-203 nm followed by a shoulder at 216 
nm, and by a weak minimum near 240 nm. This CD shape can be attributed to the presence 
of turns. Interestingly, there is no evidence for an exciton splitting in the peptide containing 
Phe-1 (IV.19b). This suggests that the α-Amp with the (2R, 1’S, 3S, 4S)-configuration 
favors a turn type, in which the side chains of Phe-1 and Tyr-5 are not able to couple.  
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Figure 26: (A) CD spectra of peptides IV.18a/b (100 μM in methanol). (B) CD spectra of peptides IV.17a/b 
(200 μM in methanol). (C) CD spectra of peptides IV.19a/b (200 μM in methanol). 
 
In order to see if the conformational properties of the α-Amp-containing peptides were 
dependent on the solvent, the CD spectra of the peptides dissolved in water were recorded 
as well (Figure 27). Peptide IV.17a showed a blue shift of the positive band from 228 to 
222 nm, but the shape remained the same as in methanol. In contrast, the exciton splitting 
observed for peptide IV.17b in methanol disappeared in water, suggesting that probably a 
more open conformation was present in water. For peptides IV.19a/b, CD spectra similar to 
those found in methanol were observed, although the CD intensity was reduced, probably 
because of a partial destabilization.  
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Figure 27: (A) CD spectra of peptides IV.17a/b (200 μM in water). (B) CD spectra of peptides IV.19a/b 
(200 μM in water). 
 
 
In summary, these data suggest that the substitution of LPro by the α-Amp unit with 
the S-configuration at the α-carbon may lead to a stabilization of a polyproline II 
conformation at the expense of a flexible structure (Figure 26A-B). However, a turn 
structure could also be induced in conjunction with additional stabilizing effects like π-π 
interactions between aromatic residues (Figure 26B). On the other hand, the α-Amp unit 
with the R-configuration at the α-carbon seems to be superior in the stabilization of a turn 
motif: indeed, the induced conformation does not significantly depend on additional π-π 
interactions and remains moderately stable in water (Figures 26C and 27B). Moreover, the 
CD shape of the peptides containing this residue (IV.19a/b) corresponds to the one 
described for the class C’ of linear α-peptides displaying Xxx-DYyy or Xxx-Gly type II β-
turns [50].  
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V.  Summary  
 
 
The Id proteins (Id1-4) are negative regulators of several bHLH transcription factors, 
including the ubiquitous E factors and the tissue-specific myogenin-regulating factors. The 
Id HLH domains consist of two helices (a N-terminal helix-1 and a C-terminal helix-2, 16 
residues each) connected by a loop of nine residues. The Id HLH sequences are highly 
conserved, whereas their N- and C-terminal extensions differ both in length and amino acid 
composition. Beside heterodimerization with the parent bHLH factors, the 134-residue long 
Id2 protein additionally interacts with the retinoblastoma protein (pRb) and, when 
overexpressed, Id2 inhibits the pRb-mediated cell-cycle arrest. As pRb is one of the most 
important tumor suppressors in the cells and Id2 is upregulated in several cancer types (e. g. 
neuroblastoma), Id2 represents an interesting target for cancer therapy based on the 
inhibition of protein-protein interactions. 
The HLH region is essential for Id protein activity; however, the N- and C-termini are 
also important for the regulation of the inhibitory effects of the Id proteins on DNA 
transcription. Here we have presented the synthesis and conformational characterization of 
peptides derived from point mutations and N-/C-terminal truncations of Id2. The helix 
character of the HLH domain (residues 36-76) could be reduced upon substitution of Met-
39/-62 and Cys-42 with Nle and Ser, respectively, suggesting that these side chains play a 
role in the HLH fold. The largest sequence that could be obtained by stepwise solid-phase 
peptide synthesis (SPPS) with Fmoc strategy spanned the entire HLH motif (with Cys-42 
replaced by Ser) and part of the C-terminus (residues 77-110). This 75-residue long 
fragment was less helical than the isolated HLH domain and had propensity to aggregate, 
which was correlated with the presence of the flanking residues C-terminal to helix-2. By 
CD analysis of an equimolar mixture of the sequence 36-110 with the N-terminus 1-35, 
noncovalent interactions between the two peptides were detected, which, however, changed 
upon aging. In contrast, the mixture of the HLH sequence 36-76 with the N-terminus was 
characterized by a stabilized helix structure that was maintained also upon aging. 
Presumably, the N-terminal region interacted with the folded HLH motif in a specific 
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manner, whereas only unspecific, weak contacts occurred with the partly unfolded HLH 
domain and/or the immediate flanking residues 77-110. 
Id2 possesses a C-terminal nuclear export signal (NES, residues 103-119) that is 
responsible for the transport of Id2 from the nucleus to the cytoplasm. C-terminal Id2 
fragments containing the NES sequence are either disordered or aggregation-prone. To 
study the conformational properties of the isolated NES region, we have synthesized the 
Id2 segment 103-124. The latter was insoluble in water and only temporarily soluble in 
water/alcohol mixtures, in which it displayed a β-sheet conformation that quickly 
precipitated in amorphous aggregates. Introduction of a positively charged N-terminal tail 
bearing three lysines prevented aggressive precipitation and led to aggregates consisting of 
long β-sheet fibrils that bound thioflavin T. On the other hand, when the positively charged 
tail was introduced at the C-terminus, the peptide was able to stay in solution for a longer 
time and to adopt a helical conformation. Transmission electron micrographs of this C-
terminally Lys-tagged NES analogue showed a highly ordered morphology consisting of 
aligned fibrils. These presumably originated from an antiparallel organization of helix 
monomers in a bilayer stabilized by favorable helix-dipole as well as hydrophobic side-
chain interactions. It was also shown that the two Lys-tagged NES peptides could associate 
in helical structures and form aggregates with a morphology similar to that observed for the 
C-terminally Lys-tagged peptide alone.  
The last part of this PhD work has been focused on the synthesis of peptidomimetics 
as potential modulators of protein-protein interactions. To this purpose, the unnatural amino 
acid 3-carboxy-cyclopentylglycine (Cpg) has been used. This scaffold presents two 
carboxylic groups separated by four carbon atoms, three of them are constrained in a 
cyclopentyl ring. Hence, one application of Cpg is the N,N-linkage of two peptide 
fragments to form covalent homodimers. This has been done for Id helix-2 fragments, and 
the effect of both enantiomers of Cpg on the conformation has been investigated by CD 
spectroscopy. It was found that the Cpg-linked dimer of the Id1 helix-2 fragment 91-101 
could interact with the native Id1 HLH motif, leading to helix stabilization or 
destabilization of the latter depending on the Cpg configuration. The Cpg-containing 
peptide was also tested on human vascular smooth muscle cells (VSMC) presenting a 
synthetic phenotype: preliminary data suggest that the peptide might influence the 
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inhibitory activity of the Id proteins, as it was able to reduce VSMC proliferation and 
migration, while inducing differentiation. However, its potency was only in the micromolar 
range and thus needs to be improved, together with the cellular uptake and, of course, 
proteolytic stability.  
A second unnatural amino acid, 3,4-(aminomethano)proline (Amp), has been used 
for the synthesis of peptidomimetics. Amp is not only a derivative of proline, but it is also a 
bicyclic γ-amino acid. In this work α/γ-alternating peptides (hexamers and octamers) 
containing both enantiomers of Amp have been synthesized by manual SPPS and 
characterized by CD and NMR spectroscopy. The results suggest that α/γ-peptides 
containing the γ-Amp building block adopt ordered secondary structures which depend on 
the configuration of the γ-amino acid. Indeed, the γ-Amp in the (2S, 1’R, 3R, 4R)-
configuration favors a helical backbone, as supported also by computational analysis, 
whereas the γ-Amp in the (2R, 1’S, 3S, 4S)-configuration might induce a bend-like 
structure. 
The Amp amino acid has been used also as a proline analogue, and in order to distinguish 
the contribution of α-Amp from that of additional favorable interactions between aromatic 
residues to induce and stabilize turns and hairpin-like structures, two pentapeptides have 
been prepared, both containing a C-terminal Tyr residue while differing in the N-terminal 
residue, which was either an alanine or a phenylalanine. CD spectroscopy data suggest that 
the substitution of LPro by the α-Amp unit with the S-configuration at the α-carbon may 
lead to a stabilization of a polyproline II conformation at the expense of a flexible structure. 
However, a turn structure could also be induced in conjunction with additional stabilizing 
effects like π-π interactions between the aromatic residues at the N- and C-ends. On the 
other hand, the α-Amp unit with the R-configuration at the α-carbon seems to be superior 
in the stabilization of a turn motif: indeed, the induced conformation does not significantly 
depend on additional π-π interactions and remains moderately stable in water. 
In conclusion, the synthetic and conformational studies on Id2 protein fragments and 
on oligomers containing new structurally constrained amino acid building blocks have 
provided interesting data concerning (i) the usefulness of the solid phase methodology for 
the preparation of large polypeptides related to the Id2 protein, (ii) the secondary structure 
propensity of the Id HLH domain and the influence of the flexible flanking regions, (iii) the 
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ability of a short Id2 fragment to form highly ordered fibrillar structures, and (iiii) the 
development of novel backbone-modified peptides with ordered conformations, which 
might become valuable tools in the design of peptidomimetics and foldamers for biological 
applications. All together, these data will help planning the future work aiming to the total 
synthesis and biophysical characterization of the Id2 protein and to the development of 
artificial modulators of the Id2 protein inhibitory activity. 
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VI.  Experimental part 
 
 
VI.1  Materials 
 
The N-α-Fmoc protected amino acids were purchased by MultiSynTech (Witten, Germany) 
and Novabiochem (Merck Biosciences GmbH, Schwalbach/Ts., Germany). Rink amide 4-
methylbenzhydrylamine (MBHA) resin and HBTU were from MultiSynTech. Wang resin 
and 2-chloro-tritylchloride resin were from Novabiochem. 
HOBt, DIPEA, DBU, TFA, triisopropylsilane (TIS), trimethylsilylbromide (TMSBr), α-
cyano-4-hydroxycinnamic acid and sinapinic acid were from Fluka (Taufkirchen, 
Germany). 
The following peptide-synthesis-grade reagents were purchased by Biosolve 
(Valkenswaard, The Netherlands): piperidine, 1-methyl-2-pyrrolidinone (NMP), DMF and 
diethylether. HPLC-grade acetonitrile (ACN) and TFA for UV spectroscopy were from 
Biosolve. Methanol-d3 and D2O for NMR measurements were from Deutero GmbH 
(Kastellaum, Germany) N,N-diisopropylcarbodiimide (DIC) was from Acros (Geel, 
Belgium). Sodium hydrogenphosphate and dihydrogenphosphate, acetic anhydride, acetic 
acid and 1,2-ethanedithiol (EDT) were obtained from Merck (Darmstadt, Germany). 
 
 
VI.2  Methods 
 
VI.2.1  Solid phase peptide synthesis (SPPS) 
 
The SPPS methodology was introduced by Bruce R. Merrifield in the early sixties 
[1], and since then it has become the method of choice for the preparation of native and 
chemically modified peptides containing up to 50 residues. Also larger polypeptides and 
small proteins with more than 100 residues have been synthesized by stepwise SPPS [2].  
The concept of SPPS is based on the build-up of the peptide backbone from the C-terminal 
to the N-terminal end, while the C-terminus is anchored to a solid support through a linker 
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(Scheme 1). Each amino acid is orthogonally protected at the α-amino group and, when 
required, at the side chain, in order to suppress polymerization. Two temporary protecting 
groups are mostly used for the N-protection: the 9-fluorenylmethyloxycarbonyl (Fmoc) and 
the tert-butyloxycarbonyl (Boc). The Fmoc group is base labile and usually removed with 
20-40% piperidine in DMF, whereas the Boc group is acid labile and can be released with 
50% TFA. After attachment of the N-α-protected C-terminal amino acid to the resin, the 
temporary N-protection is cleaved and the next N-α-protected and activated amino acid is 
coupled to the first one. The deprotection/coupling cycles are repeated till the sequence is 
completed. Finally, the crude product is cleaved from the solid support and simultaneously 
side-chain deprotected.  
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Scheme 1: SPPS of peptide amides using the Fmoc chemistry.  
 
 
 
The first solid support used by Merrifield was based on polystyrene crosslinked with 1% 
m-divinylbenzene and on a chlorobenzyl linker. This resin is known as the Merrifield resin 
and has been in the past the standard resin for the synthesis of peptide acids by Boc 
chemistry. However, strong acids like HF are required to remove the peptide chain from the 
solid support. As in the presented PhD work the SPPS has been performed in combination 
with the Fmoc chemistry, resin linkers which are labile under milder acidic conditions have 
been chosen (Figure 1). For the preparation of peptide amides, a polystyrene/1%-
divinylbenzene copolymer bearing the Rink amide MBHA linker has been used. As the 
MBHA linker is easily acylated, no preloading is necessary and the resin can be directly 
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used for the automatic synthesis. By contrast, the two resins applied in the synthesis of 
peptide acids, the 4-hydroxybenzyl (Wang) and 2-chloro-tritylchloride (trityl) resins, must 
be manually preloaded and capped before starting the automatic peptide chain assembly. 
The Wang linker is labile in concentrated TFA (>80%), whereas the trityl linker is labile 
already in the presence of 1% TFA. Therefore, the trityl resin can be used to prepare fully-
protected peptide acids which may be further modified at the C-terminus in solution. [3]. 
 
 
 
Figure 1: Chemical structures of the three different resin linkers used in this work for SPPS (the Rink amide 
MBHA resin is purchased in the Fmoc-protected form). 
 
 
VI.2.2  Circula dichroism (CD) spectroscopy 
 
CD spectroscopy is a very convenient method to study the secondary structure of 
peptides and proteins in solution [4]. The CD signal is the consequence of the absorption of 
polarized light by a chiral medium. A monochromatic plane-polarized light beam can be 
described as the sum of two vectors representing two in-phase circularly polarized beams of 
equal amplitude (EL-ER) but spinning in opposite directions with a frequency identical to 
the one of the light. When linearly polarized light passes through a chiral sample or through 
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a symmetrical chromophore placed in an asymmetrical environment, a different absorption 
for the left and the right circularly polarized light occurs. The left and right components 
indeed possess different extinction coefficients (εL and εR) and also different reflection 
indexes (nL and nR). Dichroism is the different absorption of left (AL) and right (AR) 
circularly polarized light as a function of the frequency, and can be described by the 
following equation 1: 
 
 
 
where Δε is the differential molar extinction coefficient in M−1 cm−1 or 103 cm2 mol−1, l the 
path length, c the concentration in g ml−1 and A the absorbance. 
The unit of CD is the ellipticity Θ, which is related to the absorbance by the following 
equation 2: 
 
 
 
The ellipticity Θ can be converted into the mean residue molar ellipticity [Θ]R, which is 
given in deg cm2 dmol−1, as follows (equation 3): 
 
 
where c is expressed in M, l in cm, and n is the number of residues. 
 
CD spectra show the ellipticity as a function of the wavelength and are usually 
recorded in the far UV range from 190 to 260 nm, where the peptide bond transitions ca be 
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detected. Absorptions are observed around 190 nm as a result of the peptide bond π−π* 
transitions and at 210-220 nm due to the n-π* transitions. The most common secondary 
structure elements found in peptides and proteins, α-helix, β-turn and random coil, display 
characteristic patterns for these transitions which are reflected in characteristic CD spectra, 
as shown in Figure 2. The latter can be used as references for the conformational analysis 
of peptides and proteins, for which the structure is not yet known.  
 
 
 
Figure 2: Characteristic patterns for the CD spectra of the most common secondary structures of peptides and 
proteins:  β-turn, ▲ random coil, ● β-sheet, ○ α-helix [4].  
 
 
VI.2.3  Nuclear magnetic resonance (NMR) spectroscopy  
 
One of the most common and useful tools to investigate the secondary and tertiary 
structure of peptides and proteins in solution is the NMR spectroscopy [5]. The NMR 
technique is unique among the ones available for three-dimensional structure determination 
of peptides and proteins at atomic resolution, since the sample can be investigated in 
solution. Moreover, solution parameters such as temperature, pH and salt concentration can 
be adjusted to mimic physiological conditions, a fact that, especially for bioactive 
molecules, is particularly important. NMR studies can also highlight the presence of 
conformational equilibria and the dynamics of the folding.  
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Important structural insights can be obtained from both mono- and two-dimensional 
NMR spectra. However, in the case of biopolymers, 2D NMR techniques are required for 
the complete identification and assignment of the amino acid sequence. 
A dispersion of the chemical shift values is the first indication of the presence of spatial 
folding in the polymer chain. When a polymer has a defined conformation in solution, a 
proton in the sequence will have a different microenvironment compared to those in a 
random coil, and it will be also different from the same proton contained in an identical 
residue type but at a different point of the sequence. This fact leads to different specific 
chemical shift values compared to those for an unfolded structure and to a good dispersion 
of the signals. 
The vicinal scalar coupling constants 3J are one of the most important NMR parameters, 
because their magnitude depends on the dihedral angle between vicinal hydrogens. The 
secondary structure of peptides is characterized by distinct torsion angles along the 
backbone. The well known Karplus relationship [6] between the vicinal spin-spin coupling 
constants 3J of two protons and the corresponding torsion angle Θ is as follows (equation 
4): 
 
 
 
This equation has been empirically defined for α-polypeptides on the base of 
crystallographic data for the dihedral angles φ and of NMR data for the 3JαN coupling 
constants [7], leading to the empirical coefficients A, B and C reported in equation 5, where 
Θ = | φ - 60° |: 
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Generally, values of 3JαN < 6 Hz indicate helical conformations, whereas bigger values are 
referred to unordered structures and extended conformations. Values of 3JαN of about 9 Hz 
are indicative of β-sheets. 
The presence of hydrogen bonds can be detected from mono-dimensional NMR 
spectra, as the hydrogen-bonded NHs are less sensitive to perturbations such as changing of 
temperature, concentration or solvents, than the NHs that are exposed to the solvent. The 
determination of the temperature coefficients (Δδ/ΔT) for the amide protons is based on the 
observations that, upon warming, NHs involved in hydrogen bonds display shifts at a 
smaller extent than the NHs that are exposed to the solvent [8]. Generally, values of 
−Δδ/ΔT > 4.5 ppb K−1 indicate solvent accessible amide protons, while values of −Δδ/ΔT < 
4.5 ppb K−1 are considered an indication of hydrogen bonds or buried protons. 
2D NMR experiments for peptide and protein analysis consist usually of correlation 
spectroscopy (COSY) experiments, together with total correlation spectroscopy (TOCSY) 
and nuclear Overhauser effect spectroscopy (NOESY). A COSY spectrum represents a map 
of the complete scalar coupling network in a macromolecular structure, where a cross peak 
indicates the correlation between two nuclei A and B that are separated by not more than 
three covalent bonds. More information can be obtained by the TOCSY experiment, in 
which also scalar correlations between nuclei with shared coupling partners are visible. 
Cross signals are formed between all nuclei in a spin system, and in the case of peptides 
each amino acid has a particular spin-system pattern that allows the identification of every 
residue type in the sequence. With the help of these two experiments, it is possible to assign 
completely all the chemical shifts of the protons of a peptide. Further, NOESY experiments 
allow the sequential assignment of the residues in the peptide chain. This type of 
experiment is based on the dipolar spin-spin coupling between two spins, also known as 
nuclear Overhauser effect (NOE), which takes place between two nuclei that are close in 
the space up to 5 Å. A cross peak indicates in this case, that two non-covalently bonded 
nuclei A and B are close enough to interact or to exchange. NOE cross peaks are usually 
defined as sequential distances when they are between backbone protons, or between a 
backbone proton and a β proton of residues that are nearest neighbors in the sequence. 
Medium range distances are all non-sequential signals between residues within a segment 
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of five consecutive residues. Long-range distances are between the backbone protons of the 
residues that are at least six positions away in the sequence.  
Medium and long range distances can be connected to secondary structure elements: for 
example, medium range contacts in helices are usually i; i+2, i; i+3, and i; i+4. Tight turns 
show i; i+3 distances, whereas β-sheets do not present medium range distances, since the 
polypeptide segments are almost fully extended. Short sequential and medium range 
distances that are found in known α-peptide conformations are listed in Table 1. 
 
Table 1: Short sequential and medium range distances in some 
common secondary structures of α-peptides. 
Distance 
α-
helix 
310-helix β-sheet 
dαN 3.5 3.4 2.2 
dαN (i; i+2) 4.4 3.8  
dαN (i; i+3) 3.4 3.3  
dαN (i; i+4) 4.2   
dNN 2.8 2.6 4.2-4.3 
dNN(i; i+2) 4.2 4.1  
dβN 2.5-4.1 2.9-4.4 3.2-4.7 
dαN(i; i+3) 2.5-4.4 3.1-5.1  
 
 
 
 
 
VI.2.4   Computational studies  
 
An important tool for the conformational analysis by a computational approach is the 
conformational search, which means to identify the “preferred” conformations of a 
molecule in solution [9]. Once a range of conformations is generated, an energy function is 
used to discriminate between them. As only those conformations that are located in 
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minimum points on the energy surface are considered with this approach, energy 
minimization methods play a crucial role in conformational analysis. 
It is important to recognize the difference between a conformational search and a molecular 
dynamics simulation. The conformational search is concerned exclusively with locating 
minimum energy structures, whereas the simulation generates an ensemble of states that 
includes structures which are not necessarily at energy minima. 
There are different conformational search methods. One of these is the systematic search 
that explores the conformational space by making regular and predictable changes to the 
conformation. In peptides and proteins, it is assumed that bond lengths and bond angles are 
fixed, and that the amide bond is adopting a trans configuration, therefore, only two torsion 
angles (φ and ψ, Figure 3) can vary. In the systematic search each of these rotable bonds is 
systematically changed through 360° using a fixed increment. Every conformation so 
generated is than minimized to derive the associated minimum energy conformation. The 
search stops when all possible combinations of torsion angles have been generated and 
minimized. 
 
 
 
Figure 3: Representation of torsion angles for an alanine residue. 
 
The energy is then function of the two variable considered, in this case the φ and ψ angles, 
and it can be represented in contour diagrams known as Ramachandran plots [10] (Figure 
4), which show that amino acids are restricted to a limited range of conformations. In these 
plots two regions are particularly important, corresponding to α-helix and β-sheet 
structures.  
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Figure 4: Ramachandran plots of L-amino acids in trans configuration. (A) Non-glycine and non-proline 
residues. (B) Glycine [11]. 
 
Systematic search can be done also taking into account particular constraints, like, for 
example, distance constraints coming from NMR analysis, to better understand if a peptide 
can fold or not into an ordered conformation. In this case the result of the search will 
consider only the conformations that reach a minimum energy and that, at the same time, 
do not violate the introduced distance constraints. However, even if important information 
on the secondary structure of a protein can be provided by a systematic search, this method 
cannot be used to characterize the dynamics of the folding process.  
 
 
VI.3  General procedures for peptide synthesis 
 
VI.3.1   Peptide chain assembly by automated SPPS 
 
All peptides presented in chapter II, III, and the Id helix analogues to be coupled to the 
Cpg amino acid (chapter IV), were prepared on a 0.018 mmol scale by solid-phase 
methodology using the automatic synthesizer Syro-I (MultiSynTech). Double couplings (2 × 
40 min) were performed with N-α-Fmoc-amino acids (5 equiv.) activated in situ with 
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HBTU (5 equiv.), HOBt (5 equiv.) and DIPEA (10 equiv.). Fmoc cleavage was 
accomplished by treating the peptidyl-resin with 40% piperidine in DMF/NMP (80:20 v/v) 
for 3 min, followed by a second treatment with 20% piperidine for 10 min. 
N-terminally truncated Id2 analogues were acetylated at the N-terminus by acetic anhydride 
(10 equiv.) and DIPEA (10 equiv.) in DMF for 20 min. C-terminally truncated Id2 
analogues were synthesized as C-terminally amidated peptides using the Rink amide 
MBHA resin (loading: 0.6 mmol g−1). The Id2 segments containing the entire C-terminus 
were prepared starting from the Wang resin (loading: 1.0 mmol g−1), which was first 
manually preloaded with Fmoc-Gly-OH (5 equiv.), HOBt (5 equiv.), DIC (5 equiv.) and 
DIPEA (5 equiv.). The new loading was 0.7 mmol g−1, as determined by the UV absorption 
of the fluorenylmethyl-piperidine adduct at 300 nm (ε = 7800 M−1 cm−1). The remaining 
free hydroxybenzyl groups were then acetylated. 
Peptide II.18 was synthesized starting from the trityl resin (loading: 1.6 mmol g−1), which 
was first manually preloaded with Fmoc-Gln(Trt)-OH (1 equiv.) and DIPEA (2 equiv.) in 
DCM. The new loading was 0.59 mmol g−1, as determined spectrophotometrically. The 
resin capping was then performed by washings with methanol/DIPEA/DCM. 
The peptides were cleaved from the resin and simultaneously deprotected with the mixture 
TFA/water/TIS (90:5:5 v/v) or, in the case of thiol-containing sequences, with the mixture 
TFA/water/TIS/EDT (90:3:4:3 v/v) for 2.5 h. The crude peptides were precipitated from 
ice-cold diethyl ether and recovered by centrifugation at 3 °C for 8 min. Several ether 
washes/centrifugation cycles were carried out to efficiently remove the scavengers. 
 
 
VI.3.2  Peptide chain assembly by manual SPPS for Cpg-containing peptides (IV.10-
13a/b) 
 
The enantiopure N-α-benzoyl-Cpg units (0.5 equiv.) were dissolved in DMF and 
coupled manually to the resin-bound Id fragments IV.2-9, which were first synthesized by 
automated stepwise solid phase synthesis, as described above, using DIC (0.5 equiv.) and 
HOBT (0.5 equiv.). After 24 hours reaction time at room temperature, further 0.5 equiv. of 
the activating reagents were added and the reaction was left to run for another day. The 
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reaction completion was controlled by cleaving a small amount of peptide from the resin 
and analyzing it by analytical HPLC and MALDI-ToF-MS. The peptides were finally 
cleaved from the resin and simultaneously deprotected with the mixtures TFA/water/TIS 
(90:5:5 v/v) or TFA/water/TIS/EDT (90:3:4:3 v/v) for 2.5 h. The crude peptides were 
precipitated from ice-cold diethyl ether and recovered by centrifugation at 3 °C for 8 min. 
Several ether washes/centrifugation cycles were carried out to efficiently remove the 
scavengers. 
The coupling of N-α-Fmoc-Cpg to the peptidyl-resin carrying the same sequence of 
peptide IV.2 was performed by using the procedure described above for N-α-benzoyl-Cpg. 
After an acetylation step with acetic anhydride (10 equiv.) in DMF for 30 min, the Fmoc 
cleavage was done by treating the peptidyl-resin with 5% DBU in a 60 mM HOBt solution 
in DMF for 3 min, for two times. The chain assembly of the sequence corresponding to 
(70-80)-Id1 was carried out by performing double couplings (2 × 1 h) with N-α-Fmoc-
amino acids (8 equiv.) activated with HOBt (8 equiv.) and DIC (8 equiv.). For the Fmoc 
cleavage the same DBU/HOBt solution described above was used. The N-terminus was 
then treated with acetic anhydride (10 equiv.) in DMF for 30 min. The peptides were finally 
cleaved from the resin and simultaneously deprotected with TFA/water/TIS (90:5:5 v/v) for 
2.5 h. The crude peptides were precipitated from ice-cold diethyl ether and recovered by 
centrifugation at 3 °C for 8 min. Several ether washes/centrifugation cycles were carried 
out to efficiently remove the scavengers. Analysis by HPCL and MALDI-ToF-MS on the 
crude peptides confirmed the success of the synthesis. 
 
 
VI.3.3  Peptide chain assembly by manual SPPS for Amp-containing peptides 
(IV.14-19a/b) 
 
Each oligomer was synthesized manually starting from 30 mg of Rink amide MBHA 
resin (loading: 0.7 mmol g−1). Single coupling of the N-α-Fmoc amino acids was 
performed using a mixture of amino acid/HOBt/DIC (each 4 equiv.) in DMF for 4 h. Single 
coupling of the N-γ-Fmoc Amp was carried out with 2.5 equiv. of the amino acid in the 
presence of equimolar HOBt and DIC in DMF for 16 h. The Fmoc group was removed with 
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5% DBU in a solution of 60 mM  HOBt in DMF (2 × 3 min). Each coupling and Fmoc 
cleavage step was followed by washes with DMF (3 ×). After peptide chain completion, the 
peptidyl-resin was treated with TFA/TIS/water (90:5:5 v/v) for 2.5 h, the resin was filtered 
off, ice-cold diethyl ether was added to the filtrate to induce peptide precipitation. The 
precipitate was then recovered by centrifugation at 3 °C for 8 min, washed several times 
with ice-cold ether and finally dried in vacuo. The peptides were characterized by analytical 
HPLC and MALDI-ToF-MS. 
 
 
VI.4  General procedure for peptide purification and characterization 
 
  The crude products were dissolved in 30% acetic acid and purified by preparative RP-
HPLC using an Agilent equipment and a Luna C-18(2) column from Phenomenex (10 μm, 
250 × 21.2 mm). The binary elution system was (A) 0.004% (v/v) TFA in water and (B) 
ACN. The gradient was 10-70% B over 40 min, with a flow rate of 21 ml min−1. UV 
detection was made at 220 nm. Analytical RP-HPLC was performed on the following 
equipment: L-6200A Intelligent pump from Merck, HP detector series 1050 from Agilent, 
and Luna C-18(2) column from Phenomenex (90 Å, 3 μm, 150 × 4.60 mm). The binary 
elution system was (A) 0.012% (v/v) TFA in water and (B) 0.01% (v/v) TFA in ACN. The 
gradients used were: (i) 15-70% B over 35 min for the fully protected thioester peptide 
II.18; (ii) 5-60% B over 40 min for all Amp-containing peptides in chapter IV; (iii) 10-70% 
B over 40 min for all the other peptides (the flow rate was always of 1 ml min−1). UV 
detection was made at 220 nm. The mass spectra were recorded on a Future GSG 
spectrometer (Bruchsal, Germany) for MALDI-ToF analysis, and on a ThermoQuest 
spectrometer (Finnigan) for LC-ESI analysis. 
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VI.5  Procedure for CD spectroscopy analysis 
 
The CD spectra were recorded on a JASCO J710 spectropolarimeter, using a quartz cell 
with a path length of 0.02 cm. Peptide stock solutions were prepared in phosphate buffer 
(100 mM, pH 7.3), water or methanol, and their concentration was determined by 
measuring the UV absorbance of the Tyr residues at 280 nm (ε = 1480 M−1 cm−1) [12], or 
of the fluorene group at 301 nm (ε = 7800 M–1 cm–1) for peptides IV.14a/b and IV.15a/b. 
In the case of peptides lacking any chromophore, a stock solution was prepared assuming a 
peptide content of 70%. 
For each CD spectrum ten scans were accumulated using the following parameters: 1 nm 
step resolution and band width, 2 s response time, 20 nm/min scan speed and 20 mdeg 
sensitivity. The CD spectrum of the solvent was subtracted from that of the peptide to 
eliminate interferences from the cell, solvent and optical equipment. Noise reduction was 
obtained by a Fourier transform filter with the program Origin (OriginLab Corporation, 
Northampton, MA, USA). The secondary structure element composition of the peptides 
reported in chapter II was extrapolated by submitting the experimental CD spectra to the 
Dichroweb online server [13]. 
 
 
VI.6  Procedure for NMR spectroscopy analysis 
 
  Peptides IV.14a/b and IV.15a/b were dissolved in CD3OH at the concentration of 2 
up to 4 mg ml−1. The experiments were recorded on Bruker Avance 600 (600.13 MHz). The 
1D-NMR spectra were collected between 278 K and 303 K by applying either the 
presaturation or the Watergate method to suppress the water resonance. 2D-NMR 
experiments (COSY, TOCSY, NOESY) were performed at 278 K for peptide IV.14a and at 
283 K for all others by using the presaturation method. The mixing times were 80 ms for 
TOCSY and 200 ms for NOESY. All spectra were processed with the program TOPSPIN 
of Bruker (version 1.2). 
Proton chemical shifts and TOCSY spectra are reported in the Appendix. 
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VI.7  Procedure for conformational search analysis 
 
  A systematic search on a simplified analogue of peptide IV.14b was performed by 
using the software Sybyl 7.2, considering the distance constraints found by NMR analysis. 
Moreover, the amide bond was fixed in the trans configuration. Torsion angles Ψ2, φ5, Ψ6, 
φ 9 and Ψ10 were incremented of 30° from 0° to 360°, whereas φ3, Ψ4, φ7 and Ψ8 were 
incremented of 60°. All conformations with bumps between any two atoms were not 
considered. The 225 conformations found were minimized by the Tripos force field with 
the Gesteiger-Huckel method for charges, using the dielectric constant of methanol (30) to 
reproduce the conditions used for the NMR experiments. After minimization, all 
conformations were checked against all preceding conformations by a match of all heavy 
atoms (in this case, heavy atoms are all atoms except hydrogens). All conformations with a 
root mean square (RMS) value lower than 0.3 Å were rejected. 
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VII.  Appendix: NMR data 
 
 
Table 1: Summary of chemical shifts (ppm) of peptide IV.14a at 278K   
Residue NH α-CH β-CH γ-CH Others 
Ala-1 7.58 4.03 1.30   
γ-Amp-2 8.53 
(γ-NH) 4.44 2.10 2.59 3.51 (CH2-pyrrolidine) 
Ala-3 8.9 4.24 1.33   
γ-Amp-4 8.61 
(γ-NH) 4.44 2.06 2.59 3.61 (CH2-pyrrolidine) 
Gly-5 8.79 3.89    
Tyr-6 8.25 4.51 3.04; 2.77  7.05 (ArHQ); 6.66 (ArHE) 
 
 
 
Figure 1: NH-aliphatic region (fingerprint) of the TOCSY spectrum of peptide IV.14a, recorded in CD3OH at 
278K 
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Table 2: Summary of chemical shifts (ppm) of peptide IV.14b at 283K   
Residue NH α-CH β-CH γ-CH Others 
Ala-1 7.56 4.06 1.33   
γ-Amp-2 8.55 
(γ-NH) 4.46 2.17 2.64 4.52-3.5 (CH2-pyrrolidine) 
Ala-3 8.87 4.27 1.35   
γ-Amp-4 8.63 
(γ-NH) 4.48 2.11 2.62 4.52-3.5 (CH2-pyrrolidine) 
Ala-5 8.90 4.29 1.37   
γ-Amp-6 8.63 
(γ-NH) 4.48 2.11 2.62 4.52-3.51 (CH2-pyrrolidine) 
Gly-7 8.80 3.92    
Tyr-8 8.26 4.52 3.07; 2.80  7.07 (ArHQ); 6.70 (ArHE) 
 
 
 
Figure 2: NH-aliphatic region (fingerprint) of the TOCSY spectrum of peptide IV.14b, recorded in CD3OH 
at 283 K 
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Table 3: Summary of chemical shifts (ppm) of peptide IV.15a at 283K   
Residue NH α-CH β-CH γ-CH Others 
Ala-1 7.54 4.02 1.31   
γ-Amp-2 8.48 
(γ-NH) 4.47 2.04 2.66 3.53 (CH2-pyrrolidine) 
Ala-3 8.94 4.28 1.36   
γ-Amp-4 8.6 
(γ-NH) 4.47 2.09 2.69 3.65 (CH2-pyrrolidine) 
Gly-5 8.88 4.02; 3.82    
Tyr-6 8.20 4.56 3.08; 2.79  7.06 (ArHQ); 6.69 (ArHE) 
 
 
 
Figure 3: NH-aliphatic region (fingerprint) of the TOCSY spectrum of peptide IV.15a, recorded in CD3OH at 
283 K 
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Figure 4: NH-aliphatic region (fingerprint) of the TOCSY spectrum of peptide IV.15b, recorded in CD3OH 
at 283 K. The overlapping between the signals relative to Ala-3 and Ala-5 and between Amp-4 and Amp-6 
can be observed. 
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Figure 5: 1H-NMR spectrum of peptide IV.17a, in CD3OH at 293 K 
 
 
Figure 6: 1H-NMR spectrum of peptide IV.17b, in CD3OH at 293 K 
 
 Appendix 145
 
Figure 7: 1H-NMR spectrum of peptide IV.19a, in CD3OH at 293 K 
 
 
Figure 8: 1H-NMR spectrum of peptide IV.19b, in CD3OH at 303 K 
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